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Abstract
A new series of chiral ferrosalen ligands was designed and synthesized. The
special feature of the ferrosalen ligands is that the chirality originated from the
planar chiral ferrocenyl structure. For most known salen ligands, chirality comes
from central and axial chiral centers. The key building block for the construction
of these ferrosalen ligands was synthesized stereoselectively by a chiral auxiliary
approach. This approach does not consume any chiral material, and does not
require chiral HPLC resolution. Using this method, nine ligands were prepared
using ferrocene as the starting material. In addition, the steric hindrance was
modulated by changing the cyclopentadienyl group to the more bulky
pentamethylcyclopentadienyl- and pentaphenylcyclopentadienyl- groups. The
structure of these ligands was established by 1H and 13C NMR. The structure of a
ferrosalen-Cu (II) complex was determined by single crystal X-ray diffraction
analysis.
All the chiral ferrosalen ligands were tested in catalytic asymmetric
reactions including enantioselective carbonyl-ene reaction, enantioselective
Strecker-type reaction and enantioselective silylcyanation. For the carbonyl-ene
reaction, up to 99% yield and 29% enantiomeric excess (ee) were obtained using
ligand-Co (III) as the catalysts; For the Strecker-type reaction, a maximum of 20%

xix

ee was obtained using ligand-AlCl as the catalyst; For the silylcyanation reaction,
up to 99% yield and 26% ee were obtained using ligand-AlCl as the catalyst.

xx

Chapter 1
Introduction
This chapter includes an introduction and some background information for
all the subsequent Chapters (Chapter 2, 3 and 4) of this dissertation. The
compound numbers, equations, schemes, figures and tables are restricted to each
Chapter and not continued from one Chapter to another.

1.1 General Introduction
The synthesis of enantiopure compounds has become one of the most active
areas of current chemical research. In nature, most biological molecules such as
proteins and sugars are present in only one enantiopure form, which can
distinguish the enantiomers of a chiral drug molecule. Different enantiomers of a
given drug molecule can exhibit dramatically different bioactivities. The wrong
enantiomer may be inactive, or even cause serious side effects. Of the 10 topselling drugs, nine have chiral active pharmaceutical ingredients (APIs) and six are
single enantiomers.1
The demand for efficient production of enantiopure chiral compounds
continues to rise. The increasing trend has led to explosive interests in developing
new stereoselective reactions (“asymmetric synthesis”), which is defined as the
intentional construction of enantiomers of a given constitutional isomer by means
of chemical reaction.2 There are three approaches to make enantiopure compounds:
1

(1) intramolecular chirality transfer: asymmetric control is achieved by an existing
chiral unit from the substrate (Figure 1.1a); (2) intermolecular chirality transfer:
chirality is induced by temporarily inserting a chiral-directing group into the
original achiral substrate which is removed after synthesis (Figure 1.1b); (3)
asymmetric catalysis: a chiral catalyst is used to induce the conversion of achiral
substrates to chiral products (Figure 1.1c). Among the three approaches mentioned
above, asymmetric catalysis is the preferred method.

Figure 1.1: Methods of asymmetric synthesis

1.2 Asymmetric catalysis
The advantage of asymmetric catalysis is that a small amounts of chiral
catalyst produce chiral compounds in large quantity. This advantage can be
evaluated with the chiral multiplication efficiency,

(Equation 1.1). In theory, the

efficiency of asymmetric catalysis can be ∞, while those methods using intra- and
intermolecular chirality transfer are 0.2 The advantages of enantioselective

2

catalysis have made the method one of the most explored areas of chemistry in
recent years.
major enantiomer
minor enantiomer
chiral source
Equation 1.1: Equation of chirality multiplication efficiency ( )
Most catalysts for enantioselective reactions consist of two major
components: metal catalytic center and chiral ligand. Catalytic activity is usually
related to the metal catalyst (Figure 1.2). A catalytic cycle starts with bond
activation of the substrate by coordination of the metal to the reacting site on the
substrate (R1), which is usually followed by the attachment of the second reactant
(R2). The catalytic cycle is finished by detachment of the metal catalyst to form
product. Sometimes there might be an additional step to regenerate the catalyst.3

Figure 1.2: General process of catalytic cycle

3

For a catalytic asymmetric reaction, enantioselectivity and reactivity are
mainly modulated by the chiral ligands. The combined electronic and steric effects
should maximize enantioselectivity and reactivity. Proper ligand must be chosen
to achieve efficient intermolecular chirality transfer from the catalyst to the
substrate, and make one of the enantiomeric products to form predominately.
According to the rule proposed by Cahn, Ingold, and Prelog (the CIP rule),
there are three types of chiralities: central, axial and planar.4 A chiral center is
defined as an atom in a molecule that is bonded to four different chemical species,
allowing for optical isomerism. Axial chirality is a special case of chirality in
which a molecule possesses an axis as the chiral unit – the substituents is held in
the way by the axis that is non- superposable with its mirror image. 2,2′bis(diphenylphosphino)-1,1′-binaphthyl (BINAP) is a widely used example of a
molecule with a chiral axis (Figure 1.3). Planar chirality is another type of
stereoisomerism. It results from different arrangements of out-of-plane groups
with respect to a plane. Ligands with central and axial chirality have been explored
extensively. In contrast, planar chiral ligands have received much less attention
(Figure 1.3).5 More recently, due to their unique structures and potential to solve
difficult problems in enantioselective catalysis, planar chiral ligands have started
to draw interest from the researchers. Most of the planar chiral ligands are based
on ferrocene derivatives.
4

Figure 1.3: Example ligands with different types of chirality

1.3 Chiral ferrocenyl ligands
1.3.1 Known ligands and their characteristics
Since their discovery in 1951,6 ferrocene derivatives have been showing
more and more utility in organometallic chemistry, materials science, and catalysis.
Chiral ferrocenyl structures are the most widely used type of planar chiral ligands
in asymmetric catalysis. Many chiral ferrocenyl ligands are known today.
Compared to other types of chiral ligands, chiral ferrocenyl ligands mainly have
the following characteristics:7-8
(1) Rigid conformation: To provide appropriate chiral environment for
stereo control, the ligand should not be too flexible. The ferrocene unit is rigid,
therefore, it is a good candidate for ligand framework.
(2) Planar Chirality: Planar chiral ligands can provide chiral environments
that cannot be achieved by central and axial chiral ligands. Moreover, planar
chirality can be combined with central and axial chiralities to solve more
challenging problems in asymmetric synthesis.
5

(3) Electronic effects: The electron rich Cp ring gives the ferrocenyl ligand
e-donor ability. This is particularly important in some cases. For example, by
coordinating the ferrocenyl ligand to a metal center, the reactivity can be tuned by
adjusting the electron donating ability of the ferrocene backbone.
(4) Versatility and easy modulation: Through structural modulation, a large
number of ferrocenyl ligands with different electronic and steric properties can be
easily produced.
(5) Stability: Ferrocenyl ligands are usually thermally and configurationally
stable in the solid form and in solution. They are not sensitive to moisture.
Due to the above characteristics, ferrocene-based ligands have been
successfully applied in many metal-catalyzed reactions. The most widely used
ferrocenyl ligands are multi-dentate chiral ferrocenyl phosphine ligands. Due to
their easy accessibility and high asymmetric efficiency (as shown in Figure 1.4),
1,2-disubstituted ferrocene derivatives are especially useful. These multidentate
ligands usually coordinate to the metal center using atoms such as phosphorus and
nitrogen (P,P and P,N ligands). In some cases of oxygen and sulfur (P,O and P,S
ligands) can also be used.

6

Figure 1.4: Examples of useful ferrocenyl ligands

1.3.2 Synthetic routes to chiral ferrocenyl ligands
1,1′-Disubstituted ferrocene ligands are less common than 1,2-disubstituted
ones due to side reactions in their synthesis. These include 1,2-substitution and
symmetrical substitution on both rings.9 The main synthetic methods are
7

summarized in scheme 1.1. Cullen’s method used the ring opening reaction of 1phenyl-1-phospha-[1]-ferrocenophane 1. The compound was treated with PhLi,
the anion intermediate was reacted with an electrophile. Many unsymmetrical 1,1′disubstituted ferrocene derivatives were synthesized using this method.10 The
other methods include selective transmetallation of 2a11 and selective lithiation of
2b.12-15

Scheme 1.1: Synthetic routes to 1,1′-disubstituted ferrocene ligands
For 1,2-disubstituted ferrocene ligands, Ugi was the first to report the
diastereoselelective ortho-lithiation of (R)-N,N-dimethyl-1-ferrocenylethylamine
(Ugi’s amine).16 By reacting the resulting intermediate with electrophiles, some
very useful ligands such as the Josiphos and Walphos ligands were synthesized.
For lithiation of Ugi’s amine, Two equivalents of n-BuLi together with TMEDA
can lithiate both Cp rings to give a dilithiated intermediate. The ligand ppfa (N, Ndimethyl-1-[2-(diphenylphosphino)ferrocenyl]ethylamine) was the first chiral
8

ferrocenyl phosphine ligand synthesized by Ugi’s method.17 Up to now, the Ugi’s
amine method is still one of the most widely used strategies in synthesizing
enantiopure 1,2-disubstituted ferrocenyl ligands (Scheme 1.2).

Scheme 1.2: Examples of 1,2-disubstituted ferrocenyl ligands using Ugi’s amine
In addition to multi-substituted ferrocenyl ligands, some interesting
heterocyclic ligands were also synthesized (Figure 1.4). These ligands are useful
in some reactions. For example, Fu developed an efficient method to prepare a
series of heterocyclic ferrocene type ligands. His group treated FeCl2 with Cp*Li,
and the intermediate was reacted with the lithium salt of the second planar ring
(Scheme 1.3).18-19 This method broadened the structural scope of ferrocenyl
ligands and made possible tuning enantioselectivity by inserting functional groups
9

on the cyclopentadienyl (Cp) ring with different bulkiness such as methyl and
phenyl groups. This type of ligand was found to be highly enantioselective
towards a variety of processes, such as isomerization of allylic alcohols, O-H
insertions, and cyclopropanation.18,20-27 However, the method has a drawback.
There is no selectivity in the ferrocene-building step, and racemic structures are
obtained. Most of the ligands made using this method need HPLC resolution on a
chiral column, which increases the cost and limits their applications on a large
scale.

Scheme 1.3: Examples of the synthesis of heterocyclic ferrocene-type ligands
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1.3.3 Applications of chiral ferrocenyl ligands in catalysis
Due to their excellent chemical and stereochemical features, planar chiral
ferrocenyl ligands have found wide applications in enantioselective catalysis.
Scheme 1.4 listed some examples of the applications, which include asymmetric
hydrogenation,28

asymmetric

allylic

alkylation,29

and

asymmetric

cyclopropanation.18

Scheme 1.4: Applications of selected chiral ferrocenyl ligands
11

1.4 Salen and salen-type ligands
Salen ligands are a class of ligands that have N2O2 as electron donors. They
can form tetradentate metal-salen complexes. The name salen was the
abbreviation of salicylaldehyde and ethylenediamine, which are substrates used
for the synthesis of the simplest salen ligand. Although the metal-salen motif has
been studied for over 60 years, the catalytic applications of chiral salen
derivatives began in the 1990s. After being extensively explored in the last two
decades, the salen framework has now been established as one of the most
“privileged” chiral catalysts: catalysts which are enantioselective over a wide
range of different reactions.30 Figure 1.5 listed some examples of “privileged”
catalytic groups.

Figure 1.5: Examples of “privileged” chiral ligands and catalysts
12

The major reason that salen ligands have gained such success in
asymmetric catalysis is due to the following features:
(1) Salen ligands are easy to synthesize. Preparation of salen ligand is
straightforward. They were usually obtained by the condensation of two
equivalents of a salicylaldehyde with one equivalent of a diamine. Quantitative
yield can usually be obtained (Scheme 1.5).

Scheme 1.5: Salen ligand and its synthesis
(2) The C-2 symmetry of salen ligands: The concept of C-2 symmetry in
chiral ligand was first introduced by Kagan in 1971.31 The advantage of a C-2
ligand is that it reduces the number of possible catalyst-substrate arrangements in
the transition state by factor of two. Among the “privileged” ligands,30 many of
them including salen complexes possess C-2 symmetry (Figure 1.5).32
(3) The ability of salen ligands to chelate with a wide range of metal ions:
For most of the transition metals, the corresponding metal-salen complexes have
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been reported. Scheme 1.6 lists five different synthetic routes for the preparation
of metal-salen complexes.33

Scheme 1.6: Preparation of metal-salen complexes
(4) Structural diversity of salen ligands: Once the appropriate metal is
identified for a required activity, the structure of the salen ligands can be easily
modified by modifications of the electron donors, using different chiral diamines
as the backbone, and modulations on the aldehyde component in some cases,
which allows systematic tuning of stereo and electronic effects to obtain increased
stereoselectivity.
Salen ligands were first reported in early 1990s for Sharpless
enantioselective epoxidation of simple alkenes lacking allylic hydroxyl groups. 3442

Later, they found numerous applications in other reactions. Scheme 1.7 lists

some well-developed reactions that use salen ligands. They include asymmetric
14

epoxidation,43 asymmetric Strecker reaction44 and asymmetric Diels-Alder
reaction.45

Scheme 1.7: Selected reactions that use salen ligands
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1.5 Objectives
By combining the ideas of ferrocenyl structure and chiral salen ligands
described above, we designed a new type of chiral ferrosalen ligand. It is based on
the salen framework. An enantiopure form of ferrocenyl structure was used to
build the ligands. It is worthy to mention that the stereochemistry effect can be
enhanced by using a chiral backbone on the salen structure. Because it is
convenient to change the backbone, enantioselectivity can be easily optimized.
As shown in Figure 1.6, using the ferrocenyl prototype (R)-4 or (S)-4,
different C-2 symmetric ferrosalen ligands can be easily prepared by their reaction
with different achiral and chiral diamines. The synthesis of (R)-4 and (S)-4 were
achieved by a synthetic route using ferrocene as the starting material, and the
stereoselective synthesis was completed by a known chiral auxiliary approach,
followed by a three-step aromatization. This synthetic route will be described in
Chapter 2 of this dissertation. These results were published in the following article:
Zhang, Xiang; Luck, Rudy; Fang, Shiyue. Stereoselective Synthesis of a
Chiral Ferrosalen Ligand Using a Novel Aromatization Strategy. Journal of
Organometallic Chemistry, 2010, in press. (doi:10.1016/j.jorganchem.2010.10.064)
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Figure 1.6: Examples of ferrosalen ligands which can be obtained from (R)-4
Using the strategy described in Chapter 2, eight ligands based on the
ferrocene motif with different backbones were synthesized and fully characterized.
Besides ferrocene-based chiral salen ligands, more sterically hindered chiral salen
ligands with methyl- and phenyl-substituted Cp rings were also designed. The
corresponding structure motifs (R)-5 and (S)-6 for ligand synthesis are shown in
Figure 1.7. These ligands were synthesized with pentamethyl and pentaphenyl
substituted ferrocene as the starting materials, followed by the similar synthetic
17

route as described in Chapter 2. The increased steric hindrance of these ligands is
expected to increase enantioselectivity of asymmetric reactions. This research will
be described in Chapter 3 of this dissertation, and results were submitted as the
following article:
Zhang, Xiang; Luck, Rudy; Fang, Shiyue. Ferrosalen and Ferrosalen-type Ligands:
Structural

Modulation

and

Applications

in

Asymmetric

Catalysis.

Organometallics, 2011, accepted for publication.

Figure 1.7: Building blocks for the synthesis of methyl- and phenyl- substituted
ferrocenyl salen ligands
In Chapter 4 of this dissertation, we will examine the catalytic activities of
the chiral ferrosalen ligands in three reactions: enantioselective carbonyl-ene
reaction,

enantioselective

Strecker-type

reaction

and

enantioselective

silylcyanation.
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Chapter 2
Stereoselective Synthesis of a Chiral Ferrosalen Ligand
Using an Aromatization Strategy

Xiang Zhang, Rudy L. Luck, Shiyue Fang
Journal of Organometallic Chemistry, 2010, in press.
(doi:10.1016/j.jorganchem.2010.10.064)

Reproduced with permission from Elsevier Science. Copyright © 2010 Elsevier B. V.,
see Appendix D.1.
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Stereoselective Synthesis of a Chiral Ferrosalen Ligand Using
an Aromatization Strategy

Xiang Zhang, Rudy L. Luck, Shiyue Fang*
Department of Chemistry, Michigan Technological University, 1400 Townsend
Drive, Houghton, Michigan 49931 USA

Tel: +001 (906) 487-2023; Fax: +001 (906) 487-2061; E-mail: shifang@mtu.edu

Abstract
A new chiral salen ligand based on two ferrocenyl groups is designed. Unlike
known salen ligands, of which chirality originates from central and axial chiral
centers, the chirality of this ligand comes from the planar chiral ferrocenyl groups.
The ligand is synthesized stereoselectively using a novel aromatization strategy
starting from a ferrocene derivative, which was readily prepared using a known
chiral auxiliary approach.

Keywords: Ferrosalen, Planar chiral, Salen, Ferrocene, Ligand
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Introduction
Most chiral ligands have narrow reaction scopes and can only be used to
control the stereoselectivity of a specific reaction. Salen (Figure 2.1) and salentype ligands are among a few exceptions including BINAP and bisoxazolines that
have wide applications.46 For example, salen ligands have been used for
enantioselective alkene epoxidation, aziridination and cyclopropanation; DielsAlder reactions; and kinetic resolution of racemic epoxides.46 In addition to
applications in enantioselective catalysis, salen and salen-type ligands are also
useful building blocks in supramolecular chemistry. For example, Zn(II)-salen
complexes can self-assemble into useful supramolecular architectures.47 Mn(II)salen complexes are being used for the construction of superparamagnetic single
molecule magnets.48-51 Due to the wide applications of salen and salen-type
compounds, a large number of salen analogs have been synthesized.46,52-56
Chirality of most salen ligands is attained by rendering chiral the two central
carbon centers at the 8 and 8′ positions. To solve additional problems, central and
axial chiral centers were introduced at the 3 and 3′ positions. These new
generation salen ligands have been found to give higher ees in some
reactions.39,41,57-58 In addition, chiral salen ligands based on ferrocene have also
been reported recently.59-62
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Figure 2.1: The salen ligand
In 2007, our research group initiated a project, which was aimed at
developing a new class of chiral ferrocenyl ligands based on the structural motifs 1
and 2 (Figure 2.2).63-66 In order to assess the stability of ligands containing 2, we
synthesized several model racemic compounds and resolved some of them using
chiral HPLC. These compounds were used successfully as ligands in several
reactions, which suggests that they are chemically and configurationally stable. 6366

In this article, we report the construction of a salen ligand (+)-3 (Figure 2.2)

using 2 as the building block.

Figure 2.2: Structural motifs of a new class of chiral ligands (1, 2) and a
ferrosalen ligand [(+)-3]
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Results and discussion
Having demonstrated the stability of ligands containing motif 2, a
stereoselective method for the synthesis of building blocks of such ligands, which
does not rely on chiral HPLC resolution, is highly desirable. In 2001, Kuehne’s
group developed a method for the preparation of enantiopure ferrocenyl ketone 4
(Scheme 2.1).67 They reacted (±)-4 with the anion of (+)-5 to give
diastereoisomers 6a and 6b. These isomers were readily separated with flash
column chromatography. Heating 6a and 6b in toluene gave enantiopure (+)-4 and
(-)-4 in quantitative yield. Because (±)-4 and (+)-5 can be readily prepared on
gram scales, and (+)-4 is easy to functionalize, we decided to access enantiopure
ligands containing 2 through aromatization of (+)-4 and its derivatives.

Scheme 2.1: Kuehne’s method for the resolution of ferrocenyl ketone (±)-4
In order to prepare ferrosalen ligand (+)-3, the building block (+)-9 is
required (Scheme 2.2). Enantiopure (+)-4 was easily formylated to give (+)-7.
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Installation of a double bond at the position α, β to the carbonyls of (+)-7 would
give (+)-8, which would tautomerize to (+)-9 under slightly basic or acidic
conditions. However, we found that this double bond installation was difficult to
achieve. A simple method would be heating (+)-7 with benzeneseleninic acid
anhydride in toluene.68 Under these conditions, we were able to synthesize a
compound resulting from nucleophilic substitution of the anhydride with the enol
of (+)-7. Unfortunately, heating the adduct gave an intractable mixture instead of
(+)-8 or (+)-9. Attempted induction of β-elimination by O-alkylation of the
selenoxide with allyl bromide followed by base treatment also failed. In this case,
we could isolate the alkylation product, but when this was treated with bases such
as NaH or t-BuLi, (+)-7 was obtained. Other experimental conditions involving
selenium chemistry69-70 and the β-hydride-elimination process of palladium
chemistry71 also failed. Further, the use of stoichiometric amounts of Pd(OAc)2 did
not produce (+)-8 either. Because all the methods using selenium and palladium
chemistry involve an intramolecular concerted or close to concerted elimination
step, it is possible that the steric hindrance and conformational rigidity of the
intermediates for the elimination prevented the formation of the cyclic transition
state required for the reaction. Based on this hypothesis, we next employed a twostep elimination process. To this end, (+)-7 was converted to the methyl enol ether
(+)-10 in 89% yield by stirring with dimethyl sulfate and cesium carbonate in
warm DMF (Scheme 2.3).
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Scheme 2.2: Early attempts to synthesize (+)-9 from enantiopure (+)-4

Scheme 2.3: O-Methylation of (+)-7
Next, compound 10 was subjected to halogenation in methanol using
different N-halosuccinimides. In entries 1, 2 and 5, (±)-10 was used as the
substrate to test the reaction which was obtained from (±)-4 following the
procedure similar to that of (+)-10. With NIS as the reagent, at 0 ˚C the halo
dimethyl acetal product (±)-11a was obtained in 52% yield (entry 1, Table 2.1).
Performing the reaction at room temperature increased the yield to 68% (entry 2).
When the halogenation agent was changed to NBS, at both 0 ˚C and room
temperature, product (+)-11b was isolated in 71% yield (entries 3 and 4).
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Halogenation with NCS resulted in a 57% yield of (+)-11c under similar
conditions (entry 5).
Table 2.1
Halogenation of methyl enol ether 10

Entrya
1
2
3
4
5
a

NXS
NIS
NIS
NBS
NBS
NCS

Temperature
0 ˚C
rt
0 ˚C
rt
0 ˚C

Product
(±)-11a
(±)-11a
(+)-11b
(+)-11b
(±)-11c

Yield (%)b
52
68
71
71
57c

Conditions: 10, NXS, MeOH.
Isolated yields.
c
1,4-Diazabicyclo[2,2,2]octane was added.
b

These α-halo ketone compounds were then subjected to various base
initiated β-elimination conditions. When (+)-11b was treated with potassium
carbonate in DMF at 80 ˚C, the enol ether (+)-10 was isolated (entry 1, Table 2.2).
Under similar conditions at room temperature, the stronger base cesium carbonate
resulted in small amounts of (+)-12 (entry 2); at 80 ˚C, the product was (+)-10
(entry 3). We then employed the strong and less hindered base sodium methoxide
for the reaction. In DMF at room temperature, (+)-11b was consumed in 1 hour as
evident in a TLC test, and the desired product (+)-9 was isolated in 68% yield
along with small quantities of (+)-12 (entry 4). To see if a stronger and less
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hindered base could give a higher yield, (+)-11b was stirred with sodium hydride
in DMF at room temperature; however, the yield of (+)-9 was lowered to 54%, and
(+)-10 and (+)-12 were also produced (entry 5). Treating (±)-11c with either
sodium methoxide or sodium hydride at room temperature did not yield (±)-9
(entries 6 and 8). Upon heating to 70 ˚C, (±)-12 was isolated in 40% yield in the
case of sodium methoxide (entry 7); in the case of sodium hydride, (±)-9 was
formed in 35% yield along with 20% of (±)-12 (entry 9). Based on these results
(entry 6-9), (±)-11c is not a useful substrate to prepare (±)-9. Treating the iodo
substrate (±)-11a with sodium hydride at room temperature did afford (±)-9 in 38%
yield but most of the substrates were converted to (±)-10 (entry 10).
The structure of (+)-9 was readily established with NMR and high
resolution MS. The structure of (+)-12 was first established by X-ray
crystallography (Figure 2.3), and then confirmed with NMR and MS. Suitable
crystals of the racemic (±)-12 which was obtained from (±)-4 following the same
procedure were grown because the pure enantiomer did not crystallize. Even
though compounds (+)-9 and (+)-12 are tautomers, we could not accomplish their
interconversion under either basic or acid conditions. For example, when treated
with NaH in THF at reflux temperature, (+)-12 was unreactive. Other basic
conditions such as Et3N/THF/50 ˚C, 10% K2CO3/THF/50 ˚C, and NaOMe/DMF/rt
gave similar results. With 10% KOH/THF/50 ˚C, (+)-12 partially decomposed
after 12 hours, and (+)-9 was not formed. Stirring solutions of (+)-12 in THF with
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acetic acid at room temperature returned the starting material; when heated to 50
˚C, the compound started to decompose after 5 min. Without any added base or
acid, heating (+)-12 in toluene in a sealed tube to 195 ˚C to induce a thermo 1,5hydrogen shift gave an intractable mixture after 12 hours. At lower temperatures
(170 ˚C), (+)-12 was stable. Under similar conditions described above, attempts to
convert (+)-9 to (+)-12 also failed.
Table 2.2
Synthesis of 9 via β-elimination of 11

Entry

a

Substrate

Base

T

Time

1

(+)-11b (Br)

K2CO3

80 ˚C

2

(+)-11b (Br)

Cs2CO3

3

(+)-11b (Br)

Cs2CO3

4

(+)-11b (Br)

5

Yieldb
(+)-10 (+)-12

(+)-9

12 h

40%

0%

0%

rt

4h

0%

8%

0%

80 ˚C

12 h

46%

0%

0%

NaOMe rt

1h

0%

9%

68%

(+)-11b (Br)

NaH

rt

12 h

10%

10%

54%

6

(±)-11c (Cl)

NaOMe rt

12 h

0%

0%

0%

7

(±)-11c (Cl)

NaOMe 70 ˚C

1h

0%

40%

0%

8

(±)-11c (Cl)

NaH

rt

12 h

0%

0%

0%

9

(±)-11c (Cl)

NaH

70 ˚C

12 h

0%

20%

35%

10

(±)-11a (I)

NaH

rt

12 h

54%

0%

38%

a
b

Conditions: 11, base, DMF.
Isolated yields.
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Figure 2.3: An ORTEP372 representation of complex (±)-12. The FeCp bond
distances range from 2.025(5) to 2.039(5) Å, average of 2.031(5) Å and 2.019(5) –
2.036(5) Å, average of 2.026(6) Å respectively for the Fe1 and Fe2 labeled complexes.
The corresponding Fe distances to the substituted indenyl C-atoms range from 2.034(4)
to 2.063(4) Å, average of 2.05(1) Å and 2.026(5) to 2.083(5) Å, average of 2.05(2) Å for
the Fe1 and Fe2 labeled complexes respectively. Fe1-C6 and Fe2-C21 were the largest
distances suggesting a skewed arrangement of the indenyl ligand. The corresponding
C=O ketone and alcohol C-O distances were 1.258(4), 1.352(5) Å and 1.250(5), 1.343(6)
Å for the Fe1 and Fe2 labeled complexes respectively.

Now that a stereoselective method for the preparation of building block (+)9 was developed (Table 2.2, entry 4), the synthesis of ferrosalen ligands and their
29

metal complexes can be achieved using reported procedures. For example, stirring
(+)-9 with 1,2-ethanediamine in anhydrous methanol at room temperature for 5
hours gave (+)-3 in 71% yield.73 Complexation of (+)-3 with Cu(II) to give (+)-13
was achieved by stirring with cupric acetate in ethanol and water at room
temperature for 2 hours (75%) (Scheme 2.4).74

Scheme 2.4: Synthesis of ferrosalen ligand (+)-3 and its Cu(II) complex (+)-13
Many reported methods for the synthesis of non-racemic planar chiral
ferrocenyl ligands consume stoichiometric amounts of chiral starting materials.75-76
For

example,

the

widely

used

2-ferrocenyloxazolines

and

1,1′-

bis(oxazolinyl)ferrocenes were synthesized from enantiopure amino acids.75
Additionally some highly useful planar chiral ligands and catalysts were made
non-stereoselectively and enantiomers were resolved using chiral HPLC.77
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Although Fu’s group recently made significant progress on the resolution of two
such catalysts,19 the yields of enantiopure products were still low, and the method
is not applicable to compounds that are unstable in acid or unreactive with acid, a
direct measure of the difficulties in the field. Recently, Kündig’s group developed
a catalytic enantioselective method to access planar chiral building blocks through
the desymmetrization of meso precursors.78-79 However, adapting this technology
to synthesize (+)-9 is not straightforward.
The method described in this paper does not consume any chiral starting
materials and the synthesis is stereoselective. The chiral auxiliary (+)-5 used for
resolution of (±)-4 is commercially available, and can be prepared on multigram
scales.80-81 In addition, when used for resolution of (±)-4, (+)-5 could be recovered
quantitatively and be reused repeatedly. For the installation of the double bond in
(+)-7 to synthesize (+)-9, we used a three-step method. Compared with methods
involving selenium and palladium chemistry, this route has the advantage of using
less toxic and inexpensive reagents.

Conclusions
We have designed and synthesized a new ferrosalen ligand. This ligand has
unique structural features that are expected to be beneficial for improving
enantioselectivities of some catalytic reactions. The key benzoferrocenyl building
block (+)-9 for the preparation of the ligand was synthesized stereoselectively. The
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aromatization of enantiopure (+)-7 to benzoferrocene derivative (+)-9 represents
an unprecedented strategy for the synthesis of chiral ferrocenyl ligands. This
strategy may be applicable for the preparation of other planar chiral ferrocenyl
ligands and catalysts that have previously found wide utility.77 Research on
structural modulation of the ligand and the use of such ligands to solve problems
in asymmetric catalysis is underway.

Experimental section
4.1.

(+)-(R)-η5-[5-(E)-Hydroxymethylene-4-oxo-4,5,6,7-tetrahydro-3H-indenyl]-

η5-cyclopentadienyliron [(+)-7]. A two-neck round-bottom flask charged with
enantiopure (+)-4 (1.63 g, 5.78 mmol; R-enantiomer is used as an example) and
THF (20 mL) was cooled on an ice bath. NaH (0.694 g, 17.34 mmol) was added
under positive N2 pressure. After heating the mixture to reflux for 0.5 h, HCOOEt
(1.28 g, 1.40 mL, 17.34 mmol) was added via a syringe. Reflux was continued for
an additional 2 h, and the reaction mixture was allowed to cool to rt and then to 0
˚C. Et2O (30 mL) was added, and the mixture was transferred to a separation
funnel. The organic phase was washed with 5% HCl solution (50 mL). The
aqueous portion was extracted with ether (25 mL × 3). The organic phase and
extracts were combined, washed with brine, dried over anhydrous Na2SO4, and
filtered. Solvents were removed under reduced pressure. Purification by flash
column chromatography (SiO2, hexanes/Et2O 2 : 1) gave (+)-7 as a red oil (1.68 g,
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93%): Rf = 0.40 (SiO2, hexanes/Et2O 1 : 1); [α]22D = +21° (c = 0.010, CHCl3); 1H
NMR (CDCl3) δ 7.35 (s, 1H, CHO), 4.76 (br s, 1H, H-1 or 3), 4.50 (t, J = 2.4 Hz,
1H, H-2), 4.42 (br s, 1H, H-1 or 3), 4.19 (s, 5H, Cp), 2.83 (td, J = 14.0, 5.6 Hz, 1H,
H-5), 2.88-2.25 (m, 4H, H-6 and 7);
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C NMR (CDCl3) δ 196.6 (C-4), 163.7

(CHO), 109.0 (C-5), 92.4 (C-3a or C-7a), 75.3 (C-3a or C-7a), 70.9 (C-1 or 2 or 3),
70.3 (C-1 or 2 or 3), 70.1 (Cp), 64.1 (C-1 or 2 or 3), 25.2 (C-6 or 7), 22.7 (C-6 or
7); HRMS (ESI) m/z calcd for C15H14FeO2 [M]+ 283.0421, found 283.0413.
4.2.

(+)-(R)-η5-[5-(E)-Methoxymethylene-4-oxo-4,5,6,7-tetrahydro-3H-

indenyl]-η5-cyclopentadienyliron [(+)-10]. To a two-neck

round-bottom flask

charged with (+)-7 (6.48 g, 22.98 mmol; R-enantiomer is used as an example) and
DMF (40 mL) was added Cs2CO3 (15.0 g, 45.96 mmol) under positive N2 pressure.
The mixture was heated to 50 ˚C for 1 h on an oil bath. Me2SO4 (4.38 mL, 45.96
mmol) was then added via a syringe. Heating was continued for an additional 20
min, and the reaction mixture was cooled to rt. N2-bubbled 10% K2CO3 (100 mL)
was added slowly to the flask via a syringe. The mixture was then transferred to a
separation funnel, and was extracted with Et2O (40 mL × 4). The ether extracts
were combined, dried over anhydrous Na2SO4, and filtered. Solvents were
removed under reduced pressure. The mixture contained product (+)-10 (4.39 g)
and the starting material (+)-7 (1.78 g), which were separated readily with flash
column chromatography (SiO2, hexane/Et2O 1 : 2). Product (+)-10 was obtained as
a red oil in 89% yield (based on recovered starting material): Rf = 0.35 (SiO2,
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hexane/Et2O 1 : 2); [α]22D = +30° (c = 0.013, CHCl3); 1H NMR (C6D6) δ 7.42 (d, J
= 2.4 Hz, 1H, H-COMe), 4.95 (m, 1H, H-1 or 3), 4.04 (t, J = 2.4 Hz, 1H, H-2),
3.99 (m, 1H, H-1 or 3), 3.88 (s, 5H, Cp), 3.09-3.02 (m, 1H, H on C-6 or 7), 3.04 (s,
3H, H3C-O), 2.70-2.60 (m, 1H, H on C-6 or 7), 2.21-2.15 (m, 2H, H on C-6 or 7);
13

C NMR (C6D6) δ 191.7 (C-4), 155.1 (C-OMe), 114.9 (C-5), 92.5 (C-3a or C-7a),

78.0 (C-3a or C-7a), 70.1 (C-1 or 2 or 3), 70.0 (Cp), 69.7 (C-1 or 2 or 3), 65.5 (C-1
or 2 or 3), 60.4 (OCH3), 23.1 (C-6 or 7), 22.4 (C-6 or 7); HRMS (ESI) m/z calcd
for C16H17FeO2 [M + H]+ 297.0578, found 297.0569. The E geometry of the
double bond of the methyl enol ether was established by NOE. NOE was observed
between hydrogens on the methyl group and those on C-6.
4.3.

(±)-η5-[5-endo-Dimethoxymethyl-5-exo-iodo-4-oxo-4,5,6,7-tetrahydro-3H-

indenyl]-η5-cyclopentadienyliron [(±)-11a]. A two-neck round-bottom flask was
charged with racemic (±)-10 (0.80 g, 2.71 mmol) and MeOH (20 mL), and
wrapped with aluminum foil. To the flask was added N-iodosuccinimide (0.82 g,
3.62 mmol) in 5 portions in a 20 min period under positive N2 pressure. The
reaction was complete in 10 min after addition as indicated by TLC. The mixture
was partitioned between water (40 mL) and CH2Cl2 (40 mL). The aqueous phase
was further extracted with CH2Cl2 (200 mL × 3). The combined organic phases
were washed with brine, dried over anhydrous Na2SO4, and filtered. Solvents were
removed under reduced pressure. Purification by flash column chromatography
(SiO2, hexane/Et2O 8 : 1 then 3 : 1) gave racemic (±)-11a as a red solid (0.84 g,
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68%): Rf = 0.70 (SiO2, hexane/Et2O 1 : 1); mp 138-140 ˚C; 1H NMR (CDCl3) δ
5.25 (s, 1H, H-CO2), 4.82 (br s, 1H, H-1 or 3), 4.49 (t, J = 2.4 Hz, 1H, H-2), 4.44
(br s, 1H, H-1 or 3), 4.18 (s, 5H, Cp), 3.65 (s, 3H, OCH3), 3.63 (s, 3H, OCH3),
2.56-2.50 (m, 1H, H on C-6 or 7); 2.34-2.24 (m, 3H, H on C-6 or 7);
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C NMR

(CDCl3) δ 197.3 (C-4), 108.9 (C-OMe), 90.3 (C-3a or C-7a), 72.6 (C-3a or C-7a),
71.4 (C-1 or 2 or 3), 70.3 (C-1 or 2 or 3), 70.2 (Cp), 66.4 (C-1 or 2 or 3), 59.6
(OCH3), 59.1 (OCH3), 55.8 (C-5), 31.4 (C-6 or 7), 23.0 (C-6 or 7); HRMS (ESI)
m/z calcd for C17H20FeIO3 [M + H]+ 454.9807, found 454.9797. The reaction was
also performed at 0 ˚C for 1 h, (±)-11a was obtained in 52% yield.
4.4.

(+)-(R)-η5-[(5S)-5-Bromo-5-dimethoxymethyl-4-oxo-4,5,6,7-tetrahydro-3H-

indenyl]-η5-cyclopentadienyliron [(+)-11b]. Following the same procedure used
for the preparation of (+)-11a, compound (+)-10 (6.09 g, 20.6 mmol; Renantiomer is used as an example) was reacted with N-bromosuccinimide (7.32 g,
41.2 mmol) in MeOH (50 mL) at rt. The product was purified by flash column
chromatography (SiO2, hexane/Et2O 8 : 1 then 4 : 1), and compound (+)-11b was
obtained as a red solid (5.93 g, 71%): Rf = 0.65 (SiO2, hexane/Et2O 1 : 1); mp 120122 ˚C (dec); [α]21D = + 194° (c=0.010, CHCl3); 1H NMR (CDCl3) δ 5.14 (s, 1H,
H-CO2), 4.84 (d, J = 1.6 Hz, 1H, H-1 or 3), 4.52 (t, J = 2.4 Hz, 1H, H-2), 4.48 (br
s, 1H, H-1 or 3), 4.19 (s, 5H, Cp), 3.67 (s, 3H, OCH3), 3.65 (s, 3H, OCH3), 2.772.71 (m, 1H, H on C-6 or 7), 2.57-2.53 (m, 2H, H on C-6 or 7), 2.41 (dt, J = 14.4,
2.8 Hz, 1H, H on C-6 or 7);
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C NMR (CDCl3) δ 196.1 (C-4), 107.6 (C-OMe),
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90.8 (C-3a or C-7a), 72.7 (C-3a or C-7a), 71.7 (C-1 or 2 or 3), 70.5 (C-1 or 2 or 3),
70.3 (Cp), 66.9 (C-5), 66.3 (C-1 or 2 or 3), 59.4 (OCH3), 59.2 (OCH3), 29.8 (C-6
or 7), 20.6 (C-6 or 7); HRMS (ESI) m/z calcd for C17H20BrFeO3 [M + H]+
406.9945, found 406.9942. The reaction was also performed at 0 ˚C, the same
yield was obtained.
4.5.

(±)-η5-[5-exo-Chloro-5-endo-dimethoxymethyl-4-oxo-4,5,6,7-tetrahydro-

3H-indenyl]-η5-cyclopentadienyliron [(±)-11c]. Following the same procedure
used for the preparation of (±)-11a, (±)-10 (0.60 g, 2.02 mmol) was reacted with
N-chlorosuccinimide

(0.81

g,

6.06

mmol)

in

the

presence

of

1,4-

diazabicyclo[2,2,2]-octane (0.23 g, 2.02 mmol) in MeOH (15 mL) at 0 ˚C. The
product was purified by flash column chromatography (SiO2, hexane/Et2O 4 : 1),
and (±)-11c (0.35 g) was obtained as a red solid in 57% yield (based on 90 mg
recovered starting material): Rf = 0.65 (SiO2, hexane/Et2O 1 : 2); mp 118-122 ˚C;
1

H NMR (CDCl3) δ 5.03 (s, 1H, H-CO2), 4.83 (br s, 1H, H-1 or 3), 4.53 (t, J = 2.4

Hz, 1H, H-2), 4.49 (br s, 1H, H-1 or 3), 4.19 (s, 5H, Cp), 3.67 (s, 3H, OCH3), 3.64
(s, 3H, OCH3), 2.86-2.78 (m, 1H, H on C-6 or 7); 2.68-2.58 (m, 1H, H on C-6 or
7); 2.56-2.49 (m, 1H, H on C-6 or 7), 2.44-2.36 (m, 1H, H on C-6 or 7); 13C NMR
(CDCl3) δ 196.3 (C-4), 107.4 (C-OMe), 91.1 (C-3a or C-7a), 72.6 (C-3a or C-7a),
71.7 (C-1 or 2 or 3), 70.6 (C-1 or 2 or 3), 70.3 (Cp), 70.2 (C-5), 66.1 (C-1 or 2 or
3), 59.5 (OCH3), 58.9 (OCH3), 29.1 8 (C-6 or 7), 19.3 8 (C-6 or 7); HRMS (ESI)
m/z calcd for C17H20ClFeO3 [M + H]+ 363.0450, found 363.0464.
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4.6. (+)-(R)-η5-[5-Formyl-4-hydroxy-3H-indenyl]-η5-cyclopentadienyliron [(+)-9]
and

(+)-(R)-η5-[5-(Z)-hydroxymethylidene-4-oxo-4,5-dihydro-3H-indenyl]-η5-

cyclopentadienyliron [(+)-12]. A two-neck round-bottom flask was charged with
(+)-11b (821 mg, 0.975 mmol; R-enantiomer is used as an example) and DMF (8
mL). NaOMe (574 mg, 4.87 mmol) was added at rt under positive N2 pressure.
TLC indicated that the reaction was complete in 1 h. To the reaction mixture, N2bubbled saturated NH4Cl solution (20 mL) was added via a syringe. After stirring
for an additional 30 min, N2-bubbled Et2O (25 mL) was added via a syringe. The
mixture was further stirred for 30 min. The contents were then transferred to a
separatory funnel, and the organic and aqueous layers were separated. The
aqueous layer was further extracted with Et2O (20 mL × 5). The combined organic
phases were washed with brine, dried over anhydrous Na2SO4, and filtered.
Solvents were removed under reduced pressure. TLC indicated that the mixture
contained two major spots, which corresponds to compounds (+)-9 and (+)-12.
These two compounds were purified with flash column chromatography (SiO2,
hexane/Et2O 8 : 1 then 2 : 1). Compound (+)-9 was obtained as a red solid (384
mg, 68%): Rf = 0.63 (SiO2, hexane/Et2O 1 : 1); mp 39-41 ˚C; [α]24D = +749.3° (c =
0.010, CH2Cl2); 1H NMR (CDCl3) δ 9.57 (s, 1H, CHO), 6.95 (d, J = 9.2 Hz, 1H,
H-6 or 7), 6.83 (d, J = 8.8 Hz, 1H, H-6 or 7), 5.21 (br s, 1H, H-1 or 2 or 3), 5.01
(br s, 1H, H-1 or 2 or 3), 4.42 (br s, 1H, H-1 or 2 or 3), 3.89 (s, 5H, Cp); 13C NMR
(CDCl3) δ 192.8 (CHO), 175.8 (C-4), 123.2 (C-6 or 7), 117.8 (C-6 or 7), 110.8 (C37

5), 91.0 (C-3a or C-7a), 75.0 (C-3a or C-7a), 73.1 (C-1 or 2 or 3), 69.6 (Cp), 65.3
(C-1 or 2 or 3), 62.2 (C-1 or 2 or 3); HRMS (ESI) m/z calcd for C15H12FeO2 [M]+
280.0187, found 280.0181. Compound (+)-12 was obtained as a red solid (51 mg,
9%): Rf = 0.20 (SiO2, hexane/Et2O 1 : 2); mp 151-155 ˚C (dec); [α]24D = +93.3° (c
= 0.005, Et2O); 1H NMR (CDCl3) δ 10.52 (br s, 1H, OH), 7.37 (d, J = 11.2 Hz, 1H,
HC-OH), 6.30 (s, 2H, H-6 and 7), 5.08 (br s, 1H, H-1 or 3), 4.68 (br s, 1H, H-1 or
3), 4.35 (t, J = 2.4 Hz, 1H, H-2), 3.95 (s, 5H, Cp); 13C NMR (CDCl3) δ 192.4 (C4), 153.4 (CH-OH), 126.7 (C-6 or 7), 113.2 (C-6 or 7), 108.0 (C-5), 89.2 (C-3a or
C-7a), 78.1 (C-3a or C-7a), 70.8 (C-1 or 2 or 3), 70.1 (Cp), 66.3 (C-1 or 2 or 3),
64.4 (C-1 or 2 or 3); HRMS (ESI) m/z calcd for C15H12FeO2 [M]+ 280.0187, found
280.0197. Attempts to use enantiopure (+)-12 to grow crystals were not successful.
The crystal of (±)-12 used for X-ray diffraction analysis was obtained by slow
evaporation of pentane into a solution of (±)-12 in CH2Cl2 under a N2 atmosphere
at rt. Crystallographic data are listed in Table 2.3. The crystallographic data
(excluding structure factors; CCDC no. 771464) have been deposited to the
Cambridge Crystallographic Data Centre. Copies of these data can be obtained,
free of charge, on application to CCDC, 12 Union Road, Cambridge CB2 1EZ,
UK; fax: +044 1223 336033 or via e-mail: deposit@ccdc.cam.uk or via
www.ccdc.cam.ac.uk/conts/ retrieving.html. The structure can also be found in the
supporting information.

38

Table 2.3
Crystal data and structure refinement parameters for complex (±)-12
Empirical formula

C30H24Fe2O4

Formula weight

560.19

Temperature

291(2) K

Wavelength

0.71069 Å

Crystal system, space group

Z, Calculated density

orthorhombic, Pcab
a = 12.528(2) Å
b = 13.067(2) Å
c = 30.419(5) Å
8, 1.494 Mg/m3

Absorption coefficient

1.200 mm-1

F(000)

2304

Crystal size

0.35 x 0.25 x 0.15 mm

Theta range for data collection

1.34 to 22.47 °

Limiting indices

0<=h<=13, 0<=k<=14, -1<=l<=32

Reflections collected / unique

3385 / 3242 [R(int) = 0.0267]

Completeness to theta = 22.47

100.0 %

Max. and min. transmission

0.8405 and 0.6788

Refinement method

Full-matrix least-squares on F2

Data / restraints / parameters

3242 / 0 / 325

Goodness-of-fit on F2

1.060

Final R indices [I > 2(I)]

R1 = 0.0375; wR2 = 0.0768

R indices (all data)

R1 = 0.0836; wR2 = 0.0911

Largest diff. peak and hole

0.288 and -0.290 e/A3

Unit cell dimensions
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The synthesis of 9 was also carried out under other reaction conditions
using compounds 11a-c as the starting materials. Results have been summarized in
Table 2.2.
4.7.

(+)-N,N′-Bis{(R)-[η5-(η5-cyclopentadienylironyl)-4-hydroxy-3H-5-inden-5-

ylmethylidene]}ethylenediamine [(+)-3]. The solution of (+)-9 (200.9 mg, 0.718
mmol) and 1,2-ethanediamine (21.6 mg, 0.36 mmol; R-enantiomer is used as an
example) in MeOH (10 mL) was stirred at rt under a N2 atmosphere. After 5 h, the
solvent was removed under reduced pressure. Purification of the residue by flash
column chromatography (SiO2, Et2O/MeOH/Et3N 40 : 3 : 2) gave (+)-3 as a red
foam (150 mg, 71%): Rf = 0.30 (SiO2, Et2O/MeOH/Et3N 40 : 3 : 2); [α]22D =
+566.7 (c = 0.001, CHCl3); 1H NMR (CDCl3) δ 7.13 (s, 1H, HC=N), 7.10 (s, 1H,
HC=N), 6.21 (d, J = 9.6 Hz, 2H, H-6 or 7), 6.20 (d, J = 9.2 Hz, 2H, H-6 or 7), 5.04
(br s, 2H, H-1 or 3), 4.63 (br s, 2H, H-1 or 3), 4.30 (t, J = 2.0 Hz, 2H, H-2), 3.91 (s,
10H, Cp), 3.48 (s, 4H, CH2-N);

13

C NMR (CDCl3) δ 191.1 (C-4), 155.5 (C=N),

126.1 (C-6 or 7), 113.0 (C-6 or 7), 107.3 (C-5), 89.1 (C-3a or C-7a), 77.9 (C-3a or
C-7a), 70.7 (C-1 or 2 or 3), 70.0 (Cp), 66.1 (C-1 or 2 or 3), 64.1 (C-1 or 2 or 3),
50.0 (CH2-N); HRMS (ESI) m/z calcd for C32H28Fe2N2O2 [M]+ 585.0928, found
585.0936.
4.8.

(+)-N,N′-Bis{(R)-[η5-(η5-cyclopentadienylironyl)-4-oxido-3H-inden-5-

ylmethylidene]}ethylenediaminato copper (II) [(+)-13]. A two-neck round-bottom
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flask was charged with (+)-3 (27.6 mg, 0.047 mmol; R,R-enantiomer is used as an
example) and the solvent mixture EtOH/H2O (9:1, 3.3 mL). Cupric acetate (9.5 mg,
0.047 mmol) was added under positive N2 pressure. After stirring at rt for 2 h,
volatile components were removed under reduced pressure. The deep red solid
was suspended in EtOH (2 mL) and poured onto a pad of Celite. The solid on the
Celite was further washed with cold EtOH (1 mL × 2). Then, to the Celite was
added CH2Cl2 (3 mL). The red solid was dissolved and was filtered into a clean
round-bottom flask. The Celite was further washed with CH2Cl2 (3 mL × 2). The
combined red solution was evaporated under reduced pressure giving compound
(+)-13 as a red crystalline solid (22.8 mg, 75%): [α]24D = +2551.0 (c = 0.004,
CH2Cl2); HRMS (ESI) m/z calcd for C32H26CuFe2N2O2 [M]+ 644.9989, found
644.9971. This compound is paramagnetic, and was not characterized with NMR.
The image of its LRMS is shown in Figure S2 in the supporting information.
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Abstract
Several ferrosalen and ferrosalen-type ligands, (-)-1 to (-)-10, were
prepared and fully characterized. The structure of one of these ligands ligated to
Cu(II) was determined by single-crystal X-ray diffraction analysis. In comparison
with the parent ligand (-)-1, the two six-membered rings of ligand (-)-2 are not
aromatized and the synthesis was more facile. Diastereoisomers (+)-3 and (-)-4,
containing substituents on the ethylene chain, were synthesized. The aromatized
versions of (+)-3 and (-)-4, namely (+)-5 and (-)-6, were also prepared. Further
modulation of the ethylene backbone produced ligands (+)-7 and (-)-8. Replacing
the Cp ligands with Cp* and CpPh5 gave ligands (+)-9 and (-)-10, respectively. All
these ligands were tested for catalytic asymmetric reactions, including the Co(III)catalyzed carbonyl-ene reaction, Al(III)-catalyzed Strecker reaction, and Al(III)catalyzed silylcyanation of aldehydes.
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Introduction
Salen and salen-type ligands have been widely used in asymmetric catalysis.
Most of these ligands were rendered chiral by introduction of two central chiral
centers at the 8- and 8′-positions in their backbone. To solve certain selected
problems such as enantioselective epoxidation of conjugated cis-olefins and
unfunctionalized olefins, Katsuki’s group designed and synthesized salen ligands
that contain central or axial chiral centers at the 3- and 3′-positions.39,41,57-58
Recently, salen and salen-type ligands that contain the planar chiral ferrocenyl
moieties were also reported in the literature. For example, Ballistreri and coworkers used ferrocene-containing diamines for salen-type ligand synthesis. The
resulting ligands contained one or more ferrocenyl groups in their backbone.59
Bildstein’s group incorporated one or more ferrocenyl groups into the front part of
salen-type ligands.60 Erker’s group used hydroxyferrocene as the building block
for salen-type ligand synthesis. In this case, the bulky FeCp groups are very close
to the catalytic center, which may be beneficial for stereocontrol.61-62

Figure 3.1: The two structural motifs of a new class of chiral ligands
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Three years ago, we started to develop a new class of chiral ferrocenyl
ligands based on two common structural motifs (Figure 3.1). Our preliminary
results showed that such ligands are chemically and configurationally stable, and
are compatible with several catalytic reaction conditions.63-66 More recently, we
have successfully developed a stereoselective method to access this class of
ligands such as (-)-1 (Figure 3.2). As a result, we no longer need to rely on chiral
HPLC resolution to obtain them in enantiopure form, and gram-sized quantities
can be synthesized conveniently.82 In addition, this synthetic route provided an
opportunity to modulate the steric hindrance at the ethylene backbone and at the
FeCp groups. In this paper, we wish to report the synthesis and characterization of
ligands (-)-2 to (-)-10 (Figure 3.2), and their use for the Co(III)-catalyzed
carbonyl-ene reaction, Al(III)-catalyzed Strecker reaction, and Al(III)-catalyzed
silylcyanation of aldehydes.
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Figure 3.2: Ferrosalen and Ferrosalen-type ligands

O
O + H2N
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NH2
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N
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100%
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O

N
Cu

O

(-)-12
FeCp

75%

FeCp

Scheme 3.1: Synthesis of ligand (-)-2 and the Cu(II) complex (-)-12
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Results and Discussion
The synthesis of ligand (-)-1 (both enantiomers are accessible) has been
reported previously.82 Ligand (-)-2 is the unaromatized version of (-)-1. As the
synthesis of (-)-2 is several steps shorter, it was prepared to evaluate usefulness in
asymmetric catalysis. This unaromatized ligand may also display useful electronic
and steric properties in catalysis. As shown in Scheme 3.1, enantiopure (-)-11(both
enantiomers are accessible; the S enantiomer was used)82 was condensed with 1,2ethanediamine in anhydrous methanol at room temperature.37 Ligand (-)-2 was
obtained in quantitative yield as a red foam. Stirring (-)-2 with cupric acetate in a
solvent mixture of ethanol and water at room temperature gave the Cu(II) complex
(-)-12 in 75% yield (Scheme 3.1).74 Compound (-)-12 is paramagnetic and was not
characterized by NMR, but HRMS contained a peak equal to the calculated
molecular weight. We were also successful in growing crystals for X-ray
diffraction analysis (Figure 3.3). In the solid-state structure, like most metallosalen
complexes in the absence of multidentate ancillary ligands, (-)-12 adopts a trans
configuration. Although there is no substituent at the 1,2-ethanediamino backbone,
the five-membered ring containing Cu(II) and two nitrogen atoms are in a halfchair conformation.

This produces an overall stepped conformation for the

metallosalen complex.54
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Figure 3.3: ORTEP-3 structure of (-)-12.72 Displacement ellipsoids are drawn at the
30% probability level, H atoms are represented by circles of arbritary radii. Selected
bond lengths (Å) and angles (deg) for 12: Fe1-C1 2.012(12), Fe1-C2 2.041(14), Fe1-C3
2.006(14), Fe1-C4 2.024(11), Fe1-C5 2.028(11), Fe1-C6 2.023(11), Fe1-C7 2.009(12),
Fe1-C8 2.037(11), Fe1-C9 2.067(10), Fe1-C10 2.082(11), Cu1-O1 1.927(7), Cu1-N1
1.936(8), N1-C15 1.326(14), N1-C16 1.453(13), O1-Cu1-O1′ 91.8(4), O1-Cu1-N1′
165.6(3), O1-Cu1-N1 93.9(4), N1′-Cu1-N1 83.7(6) equivalent atoms generated by -x+2,x+y+1,-z+1/3

Ligands (+)-3 and (-)-4 are diastereoisomers. In catalytic applications, they
should display different efficiencies in stereocontrol. Their syntheses were
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achieved by condensing the commercially available enantiopure (+)-13 with (+)and (-)-11 in anhydrous methanol, respectively (Scheme 3.2). Good isolated yields
were obtained. Ligands (+)-5 and (-)-6 are also diastereoisomers. They are the
aromatized version of compounds (+)-3 and (-)-4. Their syntheses were
accomplished under similar conditions for the synthesis of (+)-3 and (-)-4 using
(+)-13 and the two enantiomers of compound 14 (Scheme 3.2).82 The
ethylenediamine backbone of ferrosalen (+)-5 and (-)-6 was changed to 1,2cyclohexanediamine (-)-15 to give ligands (+)-7 and (-)-8 (Scheme 3.2) utilizing
similar synthetic conditions. Ligands (-)-3 to (-)-8 were fully characterized by 1H
and

13

C NMR and HRMS. They are stable deep red crystalline solids, and in

solution, they are stable under inert atmospheres. Upon exposure to air, the
solutions turn green, indicating oxidation occurred; this is typical for ferrocenyl
compounds. One would predict that the aromatized compounds (+)-5 to (-)-8
would be less stable than the unaromatized ones (-)-2 to (-)-4 due to the reduced
aromaticity of their ferrocenyl units. However, we did not observe any obvious
difference in their stabilities in the solid state as well in solution. Our attempts to
obtain crystals of these ligands chelating to metal centers such as Cu(II), Co(II),
and Ru(II) complexes for X-ray diffraction analysis have not been successful so
far.
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Scheme 3.2: Synthesis of ligands (+)-3 to (-)-8

A significant advantage of using the FeCp group in ligands to control
stereoselectivity of catalytic reactions is the ability to modulate its size. For
example, the Cp group can be changed to Cp* (C5Me5) and CpPh5 (C5Ph5). With
these more bulky groups, the apical positions of the catalytic center of the
ferrosalen-metal complex may be shielded to varying degrees, which may only
allow substrates to react through one specific pathway. In order to evaluate this,
enantiopure (+)-9 and (-)-10 were synthesized (Scheme 3.3). For the synthesis of
(+)-9, compound 16a83 was reacted with succinic anhydride in the presence of
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AlCl3 to give the ferrocenyl ketone 17a. Reduction of the ketone with Zn/HgCl2
resulted in compound 18a. Compound 18a was cyclized through an intramolecular
Friedel-Crafts reaction using trifluoroacetic anhydride as the activation agent to
give the racemic ferrocenyl cyclohexanone (±)-19a. To resolve the enantiomers,
commercially available enantiopure (+)-20 was deprotonated with n-BuLi and the
resulting anion reacted with ketone (±)-19a to give diastereoisomers 21xa and
21ya. These isomers could be resolved on TLC with Rf values being 0.55 and 0.40,
respectively, when the developing solvent mixture was hexanes/ether (1 : 1).
However, we only obtained 21xa in pure form. During flash column
chromatography, 21xa and 21yb slowly decomposed to give (+)-20, and the parent
ketones (+)- and (-)-19a; the other diastereoisomer 21ya was contaminated with
ketones and could not be purified. Pure 21xa was decomposed in refluxing toluene
to give enantiopure (+)-19a.67,82 Formylation of (+)-19a with ethyl formate in the
presence of sodium hydride gave (+)-22a, which was condensed with 1,2ethanediamine in anhydrous methanol to give ligand (+)-9.
For the synthesis of (-)-10, compound 16b was prepared according to a
modified literature procedure.84 This compound was converted to (±)-19b
following the same sequence of reactions used for the preparation of (±)-19a. (±)19b was then resolved using (+)-20 according to the procedure described for
resolution of (±)-19a. The two diastereoisomers 21xb and 21yb have Rf values of
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0.35 and 0.20, respectively, when the developing solvent mixture was
hexanes/ether (2 : 1). Similar to compounds 21xa and 21ya, these two
diastereoisomers were not stable; they decompose slowly, resulting in (+)-20 and
the parent ketones (+)- and (-)-19b. Because 21xb has a Rf value similar to that of
ketone 19b, we were only able to obtain pure 21yb. Removal of the chiral
auxiliary (+)-20 from 21yb in refluxing toluene gave enantiopure (-)-19b (Scheme
3.3). At this time, we were not able to obtain enantiopure (+)-19b. With
enantiopure (-)-19b in hand, the synthesis of (-)-10 was straightforward, even
though the highly bulky FeCpPh5 group could have hindered the synthesis during
the formylation and imine formation reactions. For formylation, compound (-)-22b
was obtained in 77% yield. Condensation of (-)-22b with 1,2-ethanediamine gave
ligand (-)-10 in 68% yield (Scheme 3.3).
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Scheme 3.3: Synthesis of ligands (+)-9 and (-)-10
All the ligands (-)-1 to (-)-10 were tested in the Co(III)-catalyzed carbonylene reaction (Equation 3.1a), Al(III)-catalyzed Strecker reaction (Equation 3.1b;
for ease of isolation, the product was acylated with benzoyl chloride), and Al(III)catalyzed silylcyanation of aldehydes (Equation 3.1c). Under the conditions we
have investigated, all reactions resulted in good yields but unsatisfactory
enantioselectivity. The best selectivity we achieved for the carbonyl-ene reaction
was 29% using (-)-8-Co(III) as the catalyst with a 5 mol % loading and with a
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78% yield. The major enantiomer has an R configuration. Using (+)-7, a
diastereoisomer of (-)-8, as the ligand, under the same conditions, the ee was 10%
but the yield was higher at 99%. In this case, the major enantiomer had an S
configuration. For the Strecker reaction, the best ee we obtained was 20%. The
catalyst used was (-)-1-AlCl generated in situ with 10 mol % ligand and 9 mol %
Et2AlCl. Under these conditions, the yield was quantitative. For the aldehyde
silylcyanation reaction, the best ee was 26% in an 89% yield. This was achieved
using (+)-3-AlCl as the catalyst at a loading of 5 mol %. The configuration of the
major enantiomer is S.85 With (+)-5-AlCl as catalyst and under similar conditions,
the selectivity and yield were lowered to 18% ee and 84% respectively. We
believe that the low ees obtained with ligands (-)-1 to (-)-10 can be attributed in
part to the lack of steric hindrance at the 5 and 5′ positions. Without any bulky
groups at these positions, a large area at the side opposite to the FeCp group is
open. Assuming that there are no secondary interactions between the substrates
and the catalysts, the conformations of the transition states are flexible.
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Equation 3.1: Asymmetric reactions catalyzed by ferrosalen ligands (-)-1 to (-)-10

In conclusion, we have synthesized and fully characterized nine
enantiopure

ferrosalen

ligands

and

investigated

their

applications

in

enantioselective carbonyl-ene, Strecker, and silylcyanation of aldehyde reactions.
All the ligands are compatible with these reaction conditions, and high yields were
obtained. However, the enantioselectivity was low under the conditions we tested.
The low selectivity may be a result of the lack of steric hindrance at the 5- and 5′positions of the ligands. Future work will be directed to the modulation of steric
hindrance at these positions and to the evaluation of the resulting new ligands for
catalytic enantioselective reactions.
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Experimental Section
General. All reactions were performed in oven-dried glassware under a
nitrogen atmosphere using standard Schlenk techniques. Reagents and solvents
available from commercial sources were used as received unless otherwise noted.
THF was distilled from Na/benzophenone ketyl. MeOH, CH2Cl2, and toluene were
distilled over CaH2. Thin-layer chromatography (TLC) was performed using plates
with silica gel 60F-254 over glass support, 0.25 μm thickness. Flash column
chromatography was performed using silica gel with a particle size of 32-63 μm.
1

H and 13C NMR spectra were measured at 400 MHz and 100 MHz, respectively;

chemical shifts (δ) were reported in reference to solvent peaks (residue CHCl3 at δ
7.24 ppm for 1H and CDCl3 at δ 77.00 ppm for 13C, C6D5H at δ 7.16 ppm for 1H
and C6D6 at δ 128.4 ppm for 13C). GC-MS were measured on a Shimadzu GCMSQP5050A instrument: column, DB-5MS; thickness, 0.25 μm; diameter, 0.25 mm;
length, 25m; MS, positive EI. HPLC was performed on a JASCO LC-2000Plus
System: pump, PU-2089Plus Quaternary Gradient; detector, UV-2075Plus; chiral
analytical column, Chiracel AS-H (5 μm diameter, 100 Å, 250 × 4.6 mm). All
profiles were generated by detection of UV absorbance at 260 nm using a linear
gradient solvent system: 1% to 10% 2-propanol in hexanes over 30 min at a flow
rate of 1 mL/min.
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Ferrosalen (-)-2. A solution of enantiopure (-)-11 (213 mg, 0.755 mmol)
and 1,2-ethanediamine (22.7 mg, 0.378 mmol) in dry toluene (5 mL) was stirred
under a nitrogen atmosphere at rt overnight. The solvent was removed under
reduced pressure. Pure product (-)-2 was obtained as a red foam (222 mg, 0.376
mmol, 100%): Rf = 0.1 (hexanes/CH2Cl2/Et3N 1 : 1 : 0.05); [α]21D = -308.2° (c =
0.0036, CH2Cl2); 1H NMR (CDCl3) δ 9.54 (br s, 2H), 6.48 (s, 1H), 6.45 (s, 1H),
4.67 (br s, 2H), 4.31 (t, J = 2.4 Hz, 2H), 4.23 (br s, 2H), 4.12 (s, 10H), 3.34-3.10
(m, 4H), 2.94-2.82 (m, 2H), 2.39-2.02 (m, 6H); 13C NMR (CDCl3) δ 193.0, 149.8,
101.8, 91.6, 78.7, 69.5, 69.2, 68.8, 63.8, 50.0, 28.5, 23.6; HRMS (FAB) m/z calcd
for C32H32Fe2N2O2 [M]+ 588.1163, found 588.1160.
Ferrosalen (+)-3. Following the procedure for the preparation of (-)-2, (+)11 (176 mg, 0.624 mmol) and (+)-13 (66.3 mg, 0.312 mmol) in MeOH (6 mL)
were stirred at rt overnight. The product was purified with flash column
chromatography (SiO2, hexanes/Et2O/MeOH 1 : 1 : 0.03), and (+)-3 was obtained
as a red foam (168 mg, 0.227 mmol, 73%): Rf = 0.25 (SiO2, hexanes/Et2O/MeOH
1 : 1 : 0.03); [α]21D = +105.6° (c = 0.011, CH2Cl2); 1H NMR (CDCl3) δ 10.50 (br s,
2H), 7.20-7.10 (m, 6H), 7.02-6.92 (m, 4H), 6.71 (s, 1H), 6.68 (s, 1H), 4.74 (br s,
2H), 4.36 (t, J = 2.4 Hz, 2H), 4.28 (br s, 2H), 4.21 (s, 10H), 4.15 (s, 1H), 4.14 (s,
1H), 3.10-2.98 (m, 2H), 2.47-2.16 (m, 6H);

13

C NMR (CDCl3) δ 193.4, 148.7,

138.4, 128.5, 127.7, 127.4, 102.7, 91.9, 78.9, 69.8, 69.6, 69.4, 69.0, 63.9, 28.8,
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23.6; HRMS (ESI) m/z calcd for C44H40Fe2N2O2 [M+H]+ 741.1861, found
741.1840.
Ferrosalen (-)-4. Following the procedure for the preparation of (-)-2, (-)11 (359 mg, 1.27 mmol) and (+)-13 (108 mg, 0.508 mmol) in MeOH (15 mL)
were stirred at rt overnight. The product was purified with flash column
chromatography (SiO2, hexanes/Et2O/MeOH 1 : 1 : 0.03), and (-)-4 was obtained
as a red foam (300 mg, 0.405 mmol, 80%): Rf = 0.25 (SiO2, hexanes/Et2O/MeOH
1 : 1 : 0.03); [α]21D = -541.3° (c = 0.009, CH2Cl2); 1H NMR (CDCl3) δ 10.32 (br s,
2H), 7.22-6.97 (m, 10H), 6.58 (s, 1H), 6.55 (s, 1H), 4.71 (br s, 2H), 4.33 (t, J = 2.4
Hz, 2H), 4.21 (br s, 2H), 4.14 (s, 1H), 4.13 (s, 1H), 4.09 (s, 10H), 2.85-2.72 (m,
2H), 2.26-2.09 (m, 4H), 1.92-1.79 (m, 2H);

13

C NMR (CDCl3) δ 193.1, 148.3,

138.1, 128.4, 127.6, 127.0, 102.5, 91.7, 78.8, 70.7, 69.6, 69.5, 69.3, 68.7, 63.7,
28.3, 23.4; HRMS (ESI) m/z calcd for C44H40Fe2N2O2 [M+H]+ 741.1846, found
741.1846.
Ferrosalen (+)-5. Following the procedure for the preparation of (-)-2, (+)14 (107 mg, 0.382 mmol) and (+)-13 (36.9 mg, 0.174 mmol) in THF (5 mL) were
stirred at rt for 10 h. The product was purified with flash column chromatography
(SiO2, hexanes/EtOAc 2 : 3), and (+)-5 was obtained as a red foam (53 mg, 0.072
mmol, 76%; recovered 54 mg of ferrocenyl aldehyde): Rf = 0.20 (SiO2,
hexanes/EtOAc 2 : 3); [α]21D = +2380° (c = 0.002, CH2Cl2); 1H NMR (CDCl3) δ
59

7.41 (s, 1H), 7.38 (s, 1H), 7.23-7.08 (m, 10H), 6.28 (d, J = 8.8 Hz, 2H), 6.24 (d, J
= 8.8 Hz, 2H), 5.11 (br s, 2H), 4.65 (br s, 2H), 4.61 (br s, 1H), 4.60 (br s, 1H), 4.34
(t, J = 2.4 Hz, 2H), 3.98 (br s, 10H);

13

C NMR (CDCl3) δ 191.7, 154.7, 136.8,

129.1, 128.6, 127.5, 126.3, 113.8, 108.0, 89.4, 78.1, 71.2, 70.9, 70.5, 66.6, 64.5;
HRMS (ESI) m/z calcd for C44H36Fe2N2O2 [M]+ 736.1470, found 736.1455.
Ferrosalen (-)-6. Following the procedure for the preparation of (-)-2, (-)14 (96 mg, 0.343 mmol) and (+)-13 (33.1 mg, 0.156 mmol) in THF (5 mL) were
stirred at rt for 10 h. The product was purified with flash column chromatography
(SiO2, hexanes/Et2O/MeOH 1 : 1 : 0.03), and (-)-6 was obtained as a red foam (53
mg, 0.072 mmol, 72%; 40 mg (-)-14 was recovered): Rf = 0.25 (SiO2,
hexanes/Et2O/MeOH 1 : 1 : 0.03); [α]21D = -2635° (c = 0.003, CH2Cl2); 1H NMR
(CDCl3) δ 7.30-7.09 (m, 12H), 6.12 (d, J = 9.2 Hz, 2H), 6.07 (d, J = 8.8 Hz, 2H),
5.09 (br s, 2H), 4.62 (br s, 2H), 4.54 (br s, 1H), 4.52 (br s, 1H), 4.32 (t, J = 2.4 Hz,
2H), 3.86 (s, 10H);

13

C NMR (C6D6) δ 191.4, 154.3, 136.5, 128.8, 128.3, 127.2,

125.9, 113.4, 108.0, 89.2, 77.8, 70.8, 70.0, 66.2, 64.1; HRMS (ESI) m/z calcd for
C44H36Fe2N2O2 [M]+ 736.1470, found 736.1463.
Ferrosalen (+)-7. Following the procedure for the preparation of (-)-2, (+)14 (275 mg, 0.983 mmol) and (-)-15 (56 mg, 0.492 mmol) in MeOH (10 mL) were
stirred at rt overnight. The product was purified with flash column
chromatography (SiO2, hexanes/Et2O/MeOH/Et3N 10 : 10 : 1 : 1), and (+)-7 was
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obtained as a red foam (252 mg, 0.394 mmol, 80%): Rf = 0.20-0.25 (SiO2,
hexanes/Et2O/MeOH/Et3N 10 : 10 : 1 : 1); [α]21D = +5605° (c = 0.005, CH2Cl2); 1H
NMR (CDCl3) δ 7.25 (d, J = 11.2 Hz, 1H), 7.09 (d, J = 12.0 Hz, 1H), 6.22 (d, J =
9.2 Hz, 1H), 6.18 (d, J = 9.2 Hz, 1H), 6.09 (d, J = 9.2 Hz, 1H), 6.01 (d, J = 9.2 Hz,
1H), 5.07 (br s, 1H), 5.04 (br s, 1H), 4.63 (br s, 1H), 4.62 (br s, 1H), 4.32 (t, J =
2.4 Hz, 1H), 4.30 (t, J = 2.4 Hz, 1H), 3.92 (s, 5H), 3.90 (s, 5H), 3.14-2.94 (m, 2H),
2.31-2.10 (m, 2H), 1.96-1.76 (m, 2H), 1.66-1.28 (m, 4H);

13

C NMR (CDCl3) δ

191.5, 191.4, 155.2, 126.5, 126.4, 113.3, 113.1, 107.3, 107.0, 89.7, 89.5, 78.3,
71.1, 70.9, 70.3, 70.2, 66.4, 66.2, 64.9, 64.6, 64.3, 64.1, 32.6, 32.3, 24.7, 24.5;
HRMS (ESI) m/z calcd for C36H34Fe2N2O2 [M]+ 638.1314, found 638.1308.
Ferrosalen (-)-8. Following the procedure for the preparation of (-)-2, (-)14 (404 mg, 1.443 mmol) and (-)-15 (82.4 mg, 0.722 mmol) in MeOH (15 mL)
were stirred at rt overnight. The product was purified with flash column
chromatography (SiO2, hexanes/Et2O/MeOH 1 : 1 : 0.03), and (-)-8 was obtained
as a red foam (302 mg, 0.473 mmol, 65%): Rf = 0.25 (SiO2, hexanes/Et2O/MeOH
1 : 1 : 0.03); [α]21D = -3861° (c = 0.007, CH2Cl2); 1H NMR (CDCl3) δ 7.23 (d, J =
12.0 Hz, 1H), 7.06 (d, J = 12.0 Hz, 1H), 6.20 (d, J = 9.6 Hz, 1H), 6.15 (d, J = 9.2
Hz, 1H), 6.07 (d, J = 9.2 Hz, 1H), 5.98 (d, J = 8.8 Hz, 1H), 5.04 (br s, 1H), 5.01
(br s, 1H), 4.60 (br s, 1H), 4.58 (br s, 1H), 4.28 (t, J = 2.0 Hz, 1H), 4.26 (t, J = 1.6
Hz, 1H), 3.89 (s, 5H), 3.85 (s, 5H), 3.09-2.92 (m, 2H), 2.24-1.20 (m, 8H);

13

C
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NMR (CDCl3) δ 191.1, 154.9, 126.2, 126.1, 112.9, 112.7, 106.9, 106.6, 89.4, 77.9,
70.7, 70.5, 69.9, 69.8, 66.0, 65.9, 64.4, 64.1, 63.9, 63.7, 32.2, 32.0, 24.2, 24.1;
HRMS (ESI) m/z calcd for [M]+ 638.1314, found 638.1302.
Ferrosalen-Cu(II) complex (-)-12. A two-neck round-bottom flask was
charged with (-)-2 (33.6 mg, 0.057 mmol) and the solvent mixture EtOH/H2O (9 :
1, 3.3 mL). Cupric acetate (11.44 mg, 0.057 mmol) was added under positive N2
pressure. After the mixture was stirred at rt for 2 h, volatile components were
removed under reduced pressure. The deep red mixture was suspended in EtOH (2
mL) and poured onto a pad of Celite. The solid on the Celite was further washed
with cold EtOH (1 mL × 2). Then, to the filter cake was added CH2Cl2 (3 mL).
The red solid was dissolved and was filtered into a clean round-bottom flask. The
Celite was further washed with CH2Cl2 (3 mL × 2). The combined red filtrate was
evaporated under reduced pressure, giving compound (-)-12 as a red crystalline
solid (28.0 mg, 75%): [α]22D = -1564.7° (c = 0.002, CH2Cl2); HRMS (ESI) m/z
calcd for C32H30CuFe2N2O2 [M]+ 649.0302, found 649.0275. This compound is
paramagnetic and was not characterized with NMR. The structure of this complex
was further confirmed with single-crystal X-ray diffraction analysis. A crystal
suitable for the analysis was grown by slowly diffusing pentane into a solution of
(-)-12 in CH2Cl2 at rt. Crystal data collection and processing parameters are given
in Table 1. All calculations were performed using the SHELXL-97 program suite86
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under the GUI WinGX.87 The structures were solved by direct methods and
successive interpretation of the difference Fourier maps, followed by full-matrix
least-squares refinement. All non-hydrogen atoms were refined anisotropically.
The contribution of the hydrogen atoms, in their calculated positions, was included
in the refinement using a riding model. Upon convergence, the final Fourier
difference map of the X-ray structures showed no significant peaks. All details of
the structure solution and refinements are given in the Supporting Information
(CIF data). As is evident in a packing diagram supplied as Supplementary material,
the molecules are arranged so that the cyclopentadienyl ligands are involved in  stacking with opposite sides of the salen moiety. These packing interactions
may be responsible for the slight twist away from planarity of the salen ligand.
Full listings of atomic coordinates, bond lengths and angles, and displacement
parameters for all the structures have been deposited at the Cambridge
Crystallographic Data Centre (deposition number: CCDC 816340).

63

Table 3.1
Crystal Data, Data Collection, and Structure Refinement for (-)-12
Empirical formula

C32 H30 Cu Fe2 N2 O2

Mr

649.83

Crystal Syst

trigonal

Space group

P3121 (No.152)

a, b, c / Å

11.314(3), 11.314(3), 17.897(4)

V / Å3

1984.0(8)

 / mm-1

1.913

Dcalcd / gcm-3

1.632

crystal size / mm

0.15 × 0.25 × 0.40

Z

3

T/K

291

2max / deg

50

total, unique no. of data;Rint

1471, 1353; 0.067

no. params / restraints

177/0

R1(I2(I)), wR2, Sa

0.0554, 0.1175, 1.08

w=
1/[2(Fo2)+(0.0384P)2+1.9441P]
min. / max. resd. Dens / e/Ang3

where P=(Fo2+2Fc2)/3
-0.35, 0.42
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Ferrocenyl Ketocarboxylic Acid 17a. An oven-dried two-neck roundbottom flask was flushed with argon. AlCl3 (3.195 g, 23.96 mmol) and CH2Cl2 (30
mL) were added. Compound 16a83 (5.113 g, 19.97 mmol) in CH2Cl2 (50 mL) was
then added dropwise via a cannula. The solution turned dark brown. After addition,
succinic anhydride (2.398 g, 23.96 mmol) was added under positive argon
pressure. The mixture was stirred at rt overnight. The reaction flask was cooled
with an ice bath. Ice water (80 mL) was added to the mixture slowly over about 5
min. The contents were transferred to a separatory funnel. The organic and
aqueous phases were separated. The organic phase was washed with water (50 mL
× 3), dried over anhydrous Na2SO4, and filtered. Solvents were removed under
reduced pressure. The residue was purified with flash column chromatography
(SiO2, hexanes/Et2O/CH2Cl2 2 : 1 : 1), giving 17a as a red solid (5.23 g, 74%): Rf
= 0.20 (SiO2, hexanes/Et2O/CH2Cl2 2 : 1 : 1); mp 135 ˚C (dec); 1H NMR (CDCl3)
δ 4.24 (br s, 1H), 3.99 (br s, 2H), 2.90 (br s, 2H), 2.61 (br s, 2H), 1.76 (s, 15H);
13

C NMR (CDCl3) δ 202.7, 178.6, 81.5, 80.0, 76.5, 71.7, 35.4, 29.5, 10.6; HRMS

(ESI) m/z calcd for C19H24FeO3 [M]+ 356.1080, found 356.1071.
Ferrocenyl Carboxylic Acid 18a. To a two-neck round-bottom flask
containing 17a (3.80 g, 10.67 mmol) and toluene (100 mL) was added Zn dust
(20.90 g, 319.6 mmol) and HgCl2 (1.94 g, 7.143 mmol) sequentially under positive
argon pressure. The mixture was stirred vigorously while H2O (100 mL) and then
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HCl (12.1 M, 100 mL) were added via syringe. After addition, the mixture was
heated to reflux for about 3 h. TLC indicated that 17a was completely consumed.
The reaction mixture was cooled to rt. Some solids were formed, which were
removed by filtration. The mother liquor was transferred into a separation funnel.
The aqueous phase was removed. The organic phase was washed with brine (80
mL × 2), dried over anhydrous Na2SO4, and filtered. Solvents were evaporated
under reduced pressure, giving pure 18a as a red solid (3.47 g, 95%): Rf = 0.45
(short SiO2 column, hexanes/Et2O/CH2Cl2 2 : 1 : 1); mp 61-64 ˚C; 1H NMR
(CDCl3) δ 3.69 (br s, 2H), 3.59 (br s, 2H), 2.40 (t, J = 7.2 Hz, 2H), 2.34 (t, J = 7.2
Hz, 2H), 1.95 (s, 15H), 1.87-1.80 (m, 2H); 13C NMR (CDCl3) δ 180.2, 86.7, 79.8,
71.6, 70.8, 33.5, 27.0, 26.5, 10.9; HRMS (ESI) m/z calcd for C19H26FeO2 [M]+
342.1288, found 342.1276.
Racemic ferrocenocyclohexanone (±)-19a. A two-neck round-bottom
flask was charged with 18a (3.470 g, 10.14 mmol) and CCl4 (100 mL), and
wrapped with aluminum foil. The solution was bubbled with argon for 10 min.
After the solution was cooled to 0 °C, trifluoroacetic anhydride (5.60 mL, 40.30
mmol) was added via a syringe. The mixture was stirred on an ice bath and
allowed to warm to rt gradually. TLC indicated that the reaction was complete in 3
h. The contents were transferred into a separatory funnel and partitioned between
10% NaOH (120 mL) and CH2Cl2 (80 mL). The organic phase was washed with
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brine (100 mL × 2), dried over anhydrous Na2SO4, and filtered. Volatiles were
removed under reduced pressure. Purification with flash column chromatography
(SiO2, hexanes/Et2O 2 : 1) gave (±)-19a as a red solid (2.44 g, 74%): Rf = 0.30
(SiO2, hexanes/Et2O 1 : 1); mp 102 ˚C; 1H NMR (C6D6) δ 4.28-4.26 (m, 1H), 3.63
(t, J = 2.4 Hz, 1H), 3.58-3.56 (m, 1H), 2.28-2.20 ( m, 1H), 2.17-2.09 (m, 1H),
2.04-1.77 (m, 4H), 1.56 (s, 15H); 13C NMR (C6D6) δ 201.2, 90.6, 80.6, 77.1, 75.6,
73.7, 69.7, 39.5, 23.9, 21.7, 10.3; HRMS (ESI) m/z calcd for C19H24FeO [M]+
324.1182, found 324.1172.
Enantiopure Ferrocenocyclohexanone (+)-19a. To a solution of (+)-(S)N,S-dimethyl-S-phenylsulfoximine (20, 2.80 g, 16.5 mmol) in dry THF (40 mL) at
0 °C was added a solution of n-butyllithum in hexane (2.0 M, 8.30 mL). After it
was stirred for 15 min at this temperature, the mixture was cooled to -78 °C. The
racemic (±)-19a (2.44 g, 7.53 mmol) in dry THF (60 mL) was added via cannula
dropwise over 10 min. The mixture was stirred for an additional 3 h while being
warmed to -20 °C gradually. Saturated ammonium chloride (50 mL) was then
added. The mixture was diluted with water (50 mL) and extracted with ether (50
mL × 3). The ether phase was washed with brine (100 mL), dried over anhydrous
Na2SO4, and concentrated to dryness under reduced pressure at rt. The two
diastereoisomers 21xa and 21ya were not very stable; they lose their chiral
auxiliary slowly even at rt. A quick separation with flash column chromatography
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(SiO2, hexanes/Et2O 2 : 1) gave pure 21xa as indicated by TLC (Rf = 0.55, SiO2,
hexanes/Et2O 1 : 1). However, 21ya was found to be contaminated with (±)-19a.
Because 21ya and (±)-19a have similar Rf values (Rf = 0.45, SiO2, hexanes/Et2O 1 :
1), attempts to separate them were not successful. The pure 21xa was dissolved in
dry toluene (30 mL), and the solutions were heated to reflux for 12 h. After the
solution was cooled to rt, volatiles were removed. The residue was purified with
flash chromatography (SiO2, hexanes/Et2O 2 : 1). Enantiopure (+)-19a was
obtained as a red solid (1.11 g, 91%): Rf = 0.45 (SiO2, hexanes/Et2O 1 : 1); mp 110
˚C; [α]23D = +532˚ (c = 0.018, CH2Cl2); 1H NMR (C6D6) δ 4.32 (br s, 1H), 3.63 (t,
J = 2.4 Hz, 1H), 3.56 (br s, 1H), 2.30-2.22 (m, 1H), 2.16-2.08 (m, 1H), 2.03-1.76
(m, 4H), 1.57 (s, 15H); 13C NMR (C6D6) δ 201.2, 90.6, 80.6, 77.2, 75.5, 73.7, 69.8,
39.5, 23.9, 21.7, 10.3; HRMS (ESI) m/z calcd for C19H24FeO [M]+ 324.1182,
found 324.1173. The impure 21ya was also heated in toluene to give (-)-19a,
which was contaminated with (+)-19a (totally 1.20 g). The chiral auxiliary 20 was
recovered without losing any optical purity. The combined yield of 20 from 21xa
and 21ya was 89% (2.50 g).
Formylated Ferrocenocyclohexanone (+)-22a. In a two-neck roundbottom flask was charged (+)-19a (124.0 mg, 0.380 mmol) and NaH (153.0 mg,
3.82 mmol) under nitrogen. THF (15 mL) and ethyl formate (0.308 mL, 3.82
mmol) were added via syringe sequentially. The mixture was heated to reflux for
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3 h. TLC indicated that the reaction was complete. After the mixture was cooled
to rt, water (30 mL) was added, and the contents were transferred into a separatory
funnel. The mixture was extracted with ether (15 mL × 3). The combined ether
extracts were washed with brine (30 mL), dried over anhydrous Na2SO4, and
concentrated

under

reduced

pressure.

Purification

with

flash

column

chromatography (SiO2, hexanes/Et2O 4 : 1) gave (+)-22a as a red solid (125.0 mg,
93%): Rf = 0.60 (SiO2, hexanes/Et2O 1 : 1); mp 130 ˚C (dec); [α]23D = +659˚ (c =
0.018, CH2Cl2); 1H NMR (C6D6) δ 7.21 (br s, 1H), 4.29 (m, 1H), 3.72 (t, J = 2.8Hz,
1H), 3.58 (m, 1H), 2.33-2.23 (m, 1H), 2.12-1.92 (m, 4H), 1.54 (s, 15H); 13C NMR
(C6D6) δ 195.4, 164.6, 109.2, 90.4, 81.2, 76.4, 74.2, 68.9, 24.6, 20.9, 10.3; HRMS
(ESI) m/z calcd for C20H24FeO2 [M]+ 352.1131, found 352.1117.
Ferrosalen (+)-9. Following the procedure for the preparation of (-)-2, (+)22a (122.0 mg, 0.345 mmol) and 1,2-ethanediamine (11.5 µL, 0.172 mmol) in
MeOH (5 mL) were stirred at 50 ˚C for 2 h. The product was purified with flash
column chromatography (SiO2, hexanes/Et2O/MeOH 1 : 1 : 0.08), and (+)-9 was
obtained as a red solid (101 mg, 80%): Rf = 0.35 (SiO2, hexanes/Et2O/MeOH 1 : 1 :
7.5%); mp 82˚C (dec); [α]23D = +120˚ (c = 0.015, CH2Cl2); 1H NMR (C6D6) δ 9.72
(br s, 2H), 6.12 (s, 1H), 6.09 (s, 1H), 4.50 (br s, 2H), 3.70 (t, J = 2.4 Hz, 2H), 3.57
(br s, 2H), 2.70-2.57 (m, 2H), 2.50-2.11 (m, 10H), 1.71 (s, 30H); 13C NMR (C6D6)
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δ 192.3, 148.9, 102.3, 89.9, 80.5, 79.8, 74.7, 72.6, 69.0, 49.9, 28.5, 22.0, 10.5;
HRMS (ESI) m/z calcd for C42H52Fe2N2O2 [M]+ 728.2733, found 728.2730.
Ferrocene 16b. This compound was synthesized using a modified literature
procedure.84 To a solution of 1-bromopentaphenylcyclopentadiene (132 mg, 0.25
mmol) in benzene (5 mL) was added Fe(CO)5 (59.0 mg, 0.30 mmol) under
nitrogen. The mixture was heated to reflux for 3 h. After the mixture was cooled to
rt, a solution of CpNa (0.263 mL of 2.0 M in THF, 0.525 mmol) was added via
syringe. The mixture was stirred at rt for 18 h. The resulting orange mixture was
filtered through Celite. The filtrate was collected, and solvents were removed
under reduced pressure. The orange residue was heated to 160 °C under vacuum
for 3 h. After it was cooled to rt, the remaining mixture was suspended in toluene
and filtered through Celite. The filtrate was collected, and solvents were removed.
Purification by recrystallization in hot toluene gave 16b as a red crystalline solid
(115 mg, 81%).
Ferrocenyl Ketocarboxylic Acid 17b. Following a procedure similar to
that for the preparation of 17a, the reaction of 16b (1.882 g, 3.325 mmol), AlCl3
(0.935 g, 7.012 mmol), and succinic anhydride (0.332 g, 3.323 mmol) in CH2Cl2 at
reflux temperature in 24 h gave 17b as a red foam after purification with flash
column chromatography (SiO2, hexanes/Et2O 1 : 1; 1.65 g, 75%): Rf = 0.15 (SiO2,
hexanes/Et2O 1 : 1); 1H NMR (CDCl3) δ 7.18-7.01 (m, 25H), 4.88 (br s, 2H), 4.50
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(br s, 2H), 2.80 (t, J = 7.2 Hz, 2H), 2.39 (t, J = 7.2 Hz, 2H); 13C NMR (CDCl3) δ
201.9, 178.3, 134.7, 132.1, 127.2, 126.6, 88.2, 83.1, 79.0, 74.8, 36.2, 27.9; HRMS
(ESI) m/z calcd for C44H34FeO3 [M+H]+ 667.1936, found 667.1948.
Ferrocenyl Carboxylic Acid 18b. Following a procedure similar to that
for the preparation of 18a, the reduction of 17b (1.65 g, 2.477 mmol) with Zn dust
(4.860 g, 74.31 mmol) and HgCl2 (0.450 g, 1.657 mmol) in toluene (20 mL), H2O
(20 mL) and HCl (12.1 M, 20 mL) at reflux temperature in 24 h gave 18b as a red
solid after purification with flash column chromatography (short SiO2 column,
hexanes/Et2O 2 : 1; 1.35 g, 84%): Rf = 0.30 (SiO2, hexanes/Et2O 1 : 1); mp 192 ˚C;
1

H NMR (CDCl3) δ 7.15-7.01 (m, 25H), 4.15 (br s, 2H), 4.12 (br s, 2H), 2.30-2.18

(m, 4H), 1.79-1.68 (m, 2H); 13C NMR (CDCl3) δ 179.1, 135.9, 132.4, 127.1, 126.1,
90.5, 87.6, 75.0, 74.1, 33.2, 26.7, 26.5; HRMS (ESI) m/z calcd for C44H36FeO2
[M]+ 652.2065, found 652.2075. The compound may decompose slowly at rt and
storing at -20 °C is suggested.
Racemic Ferrocenocyclohexanone (±)-19b. Following a procedure similar
to that for the preparation of (±)-19a, cyclization of 18b (424.0 mg, 0.650 mmol)
to give (±)-19b was achieved with trifluoroacetic anhydride (1.0 mL, 7.195 mmol)
in CCl4 (15 mL) at 50 ˚C overnight. Purification with flash column
chromatography (SiO2, hexanes/CH2Cl2/Et2O 20 : 20 : 1) gave the product as a
red solid (375.0 mg, 91%): Rf = 0.30 (hexanes/CH2Cl2/Et2O 20 : 20 : 1); mp 220
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˚C (dec); 1H NMR (CDCl3) δ 7.16-6.98 (m, 25H), 4.84-4.82 (m, 1H), 4.45-4.43 (m,
1H), 4.37 (t, J = 2.4 Hz, 1H), 2.65-2.55 (m, 1H), 2.44-2.28 (m, 3H), 2.02-1.94 (m,
1H), 1.77-1.64 (m, 1H);
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C NMR (CDCl3) δ 203.9, 134.5, 132.2, 127.2, 126.5,

94.4, 87.7, 78.4, 77.8, 77.2, 72.8, 39.5, 24.9, 21.8; HRMS (ESI) m/z calcd for
C44H34FeO [M]+ 634.1965, found 634.1959.
Enantiopure ferrocenocyclohexanone (-)-19b. Following a procedure
similar to that for the resolution of (±)-19a, (±)-19b (437.0 mg, 0.688 mmol) was
first converted to 21xb and 21yb using (+)-(S)-20 (349.0 mg, 2.065 mmol) and nbutyllithum in hexane (2.0 M, 1.032 mL) in THF. Because the two
diastereoisomers 21xb and 21yb slowly lose the chiral auxiliary even at rt, they
were quickly separated with flash column chromatography (short SiO2 column,
hexanes/CH2Cl2/EtOAc 20 : 10 : 1). TLC analysis indicated that 21xb was still
contaminated with (±)-19b. Because their Rf values were very close (Rf = 0.35,
SiO2, hexanes/Et2O 2 : 1), attempts to separate them were not successful. However,
the other diastereoisomer 21yb, which had an Rf value of 0.20 (SiO2,
hexanes/Et2O 2 : 1), was obtained in pure form. The solution of 21yb in dry
toluene (10 mL) was then heated to reflux overnight. Enantiopure (-)-19b was
obtained as a red solid (171 mg, 78%): Rf = 0.35 (SiO2, hexanes/CH2Cl2/EtOAc
20 : 10 : 1); mp 220 ˚C (dec); [α]23D = -311˚ (c = 0.0095, CH2Cl2); 1H NMR
(CDCl3) δ 7.17-6.96 (m, 25H), 4.83 (br s, 1H), 4.44 (br s, 1H), 4.38 (br s, 1H),
72

2.66-2.55 (m, 1H), 2.45-2.28 (m, 3H), 2.02-1.93 (m, 1H), 1.79-1.64 (m, 1H); 13C
NMR (CDCl3) δ 204.0, 134.5, 132.2, 127.2, 126.5, 94.4, 87.7, 78.4, 77.8, 77.2,
72.8, 39.5, 24.9, 21.8; HRMS (ESI) m/z calcd for C44H34FeO [M]+ 634.1965,
found 634.1956. The impure 21xb was also heated in toluene to give (+)-19b,
which was contaminated with (-)-19b (total 262 mg). The chiral auxiliary 20 was
recovered without losing any optical purity. The combined yield of 20 from 21xb
and 21yb was 86% (300 mg).
Formylated Ferrocenocyclohexanone (-)-22b. A procedure similar to that
for the synthesis of (+)-22a was followed. Compound (-)-19b 171.0 mg, 0.269
mmol), NaH (214.0 mg, 5.380 mmol), and ethyl formate (0.434 mL, 5.380 mmol)
in THF (20 mL) were heated to reflux overnight. After the mixture was cooled to
rt, saturated NH4Cl (30 mL) was added. The mixture was extracted with EtOAc
(15 mL × 2). The organic phase was washed with brine (30 mL), dried over
anhydrous Na2SO4, and concentrated under reduced pressure. Purification by flash
column chromatography (short SiO2 column, hexanes/CH2Cl2/EtOAc 40 : 10 : 1)
gave (-)-22b as a red solid (138.0 mg, 77%). The product may decompose slowly
on silica gel. Enantiopure (-)-22b: Rf = 0.25 (SiO2, hexanes/Et2O 5 : 1); mp 210 ˚C
(dec); [α]22D = -197˚ (c = 0.009, CH2Cl2); 1H NMR (CDCl3) δ 7.50-7.43 (br s, 1H),
7.20-6.96 (m, 25H), 4.86 (t, J = 2.0Hz, 1H), 4.42 (br s, 1H), 4.41 (br s, 1H), 2.682.58 (m, 1H), 2.44-2.24 (m, 3H); 13C NMR (CDCl3) δ 194.7, 165.4, 134.6, 132.5,
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127.4, 126.7, 111.1, 91.4, 88.3, 78.7, 78.4, 77.7, 73.2, 25.6, 21.4; HRMS (ESI) m/z
calcd for C45H34FeO2 [M]+ 662.1914, found 662.1904.
Ferrosalen (-)-10. Following the procedure for the preparation of (-)-2, (-)22b (40.0 mg, 0.0604 mmol) and 1,2-ethanediamine (1.68 μL, 0.0251 mmol) in
MeOH (5 mL) were stirred at 50 ˚C for 24 h. Purification by flash column
chromatography (SiO2, hexanes/Et2O/MeOH 1 : 1 : 0.02) gave (-)-10 as a red solid
(23.0 mg, 68%): Rf = 0.10 (SiO2, hexanes/Et2O 1 : 1); mp 124-127 ˚C; [α]22D = 69˚ (c = 0.0225, CH2Cl2); 1H NMR (CDCl3) δ 9.38 (br s, 2H), 7.14-6.96 (m, 50H),
6.46 (s, 1H), 6.43 (s, 1H), 4.75 (br s, 2H), 4.24 (br s, 4H), 3.32-3.20 (br s, 2H),
3.14-3.00 (br s, 2H), 2.58-2.06 (m, 8H); 13C NMR (CDCl3) δ 192.0, 149.1, 135.2,
132.7, 127.2, 126.3, 103.9, 91.3, 87.9, 82.0, 77.0, 76.6, 72.7, 50.4, 29.2, 22.2;
HRMS (ESI) m/z calcd for C92H72Fe2N2O2 [M]+ 1348.4293, found 1348.4292;
calcd for [M+H]+ 1349.4365, found 1349.4360.
Enantioselective Carbonyl-ene Reaction Catalyzed with FerrosalenCo(III) Complexes.88 Ligand (-)-8 is used as an example. In a round-bottom flask
containing (-)-8 (190 mg, 0.298 mmol) and MeOH (10 mL) was added Co(OAc)2 •
4H2O (74.2 mg, 0.298 mmol) in MeOH (5 mL) via a cannula. The mixture was
stirred at rt for 1 h. The solvent was removed under reduced pressure on a rotary
evaporator. The flask, which contained the residue, was then wrapped with
aluminum foil. CH2Cl2 (15 mL) was added via syringe, which was followed by
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addition of AgSbF6 (205 mg, 0.596 mmol). The mixture was stirred at rt overnight.
The resulting black suspension was poured onto a pad of Celite, which was
washed with CH2Cl2. The filtrate was discarded. The Celite pad was then washed
with acetone. The filtrate was concentrated to dryness under reduced pressure to
give the Co(III) complex. The compound was used directly as a catalyst for the
carbonyl-ene reaction without further purification. Ethyl glyoxylate (50% in
toluene; 250.9 mg, 1.23 mmol) was heated to reflux under nitrogen for 1 h to crack
its dimer. After it was cooled to rt, the solution was added to a round-bottom flask
containing (-)-8 -Co(III) (19.0 mg, 0.02 mmol) in dry toluene (3 mL). The mixture
was stirred at rt for 10 min. α-Methylstyrene (48.2 mg, 0.41 mmol) was then
added via syringe in one portion. The reaction was allowed to proceed at rt, and
the progress was monitored with GC-MS. After 16 h, the mixture was passed
through a pad of Celite, which was washed with CH2Cl2 (3 mL × 3). Volatiles
were removed under reduced pressure. The residue was purified with flash column
chromatography (SiO2, hexanes/Et2O 4 : 1). The product 2388 was obtained as a
colorless oil (70.0 mg, 78%). The ee was determined with chiral HPLC using the
conditions described in the general experimental section. The enantiomers S-23
and R-23 were eluted at 17.0 and 21.0 min, respectively. The ee was 29% with R23 being the major enantiomer. In addition to ligand (-)-8, all other ligands,
including (-)-1, (-)-2, (+)-3, (-)-4, (+)-5, (-)-6, (+)-7, (+)-9, and (-)-10 were also
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tested for the reaction. The yields ranged from 20% to 99%. The ees ranged from
0% to 10%.
Enantioselective Strecker Reaction Catalyzed with Ferrosalen-Al(III)
Complexes.44 Ligand (-)-1 is used as an example. In a round-bottom flask
containing ligand (-)-1 (18.0 mg, 0.031 mmol) and dry CH2Cl2 (5 mL) was added
Et2AlCl (1.0 M solution in hexanes, 27.8 µL, 0.028 mmol) via syringe. The
mixture was stirred at rt for 2 h under nitrogen. (E)-N-Butylideneprop-2-en-1amine (34.5 mg, 0.31 mmol) was added via syringe. After the mixture was cooled
to -78 °C, a solution of TMSCN (62 µL, 0.456 mmol) in CH2Cl2 (2 mL) was
added via a cannula dropwise. The reaction mixture was warmed to rt gradually
over 12 h. Pyridine (2 mL) was added, which was followed by benzoyl chloride
(0.5 mL). The mixture was stirred for 1 h. Solvent was removed under reduced
pressure. The residue was purified by flash column chromatography (SiO2,
hexanes/Et2O 10 : 1 to 5 : 1) to give pure product 24 as a colorless oil (77.9 mg,
100%).44 The ee was determined with chiral HPLC using the conditions described
in the general experimental section. The enantiomers (-)-24 and (+)-24 were eluted
at 19.1 and 20.0 min, respectively. The ee was 20% with (+)-24 being the major
enantiomer. In addition to ligand (-)-1, all other ligands, including (-)-2, (+)-3, (-)4, (+)-5, (-)-6, (+)-7, (-)-8, (+)-9, and (-)-10 were also tested for the reaction. The
yields were all quantitative. The ees ranged from 0% to 18%.
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Enantioselective Silylcyanation of an Aldehyde.62 Ligand (+)-3 is used as
an example. In a round-bottom flask under nitrogen was charged (+)-3 (15.2 mg,
0.0205 mmol) and CH2Cl2 (1 mL). Et2AlCl (20.5 uL of 1.0 M solution in hexanes,
0.0205 mmol) was added via syringe. The mixture was stirred at rt for 5 h. Oct3PO
(23.8 mg, 0.0616 mmol) in CH2Cl2 (1 mL) was then added via cannula. After the
mixture was cooled to -20 °C, freshly distilled benzaldehyde (43.6 mg, 0.41 mmol)
and trimethylsilylcyanide (136 μl, 1.025 mmol) were added via syringe
sequentially. The reaction was allowed to proceed at -20 °C, monitored with GCMS, and found complete in 24 h. Volatiles were removed under reduced pressure.
The residue was suspended in ether and passed through a 1-inch pad of silica gel
to remove the catalyst. The filtrate was concentrated to dryness. Purification with
flash column chromatography (SiO2, hexanes/Et2O 10 : 1) gave product 2562 as a
colorless liquid (76.0 mg, 89%). The ee was determined with chiral HPLC using
the conditions described in the general experimental section. The enantiomers S25 and R-25 were eluted at 4.9 and 6.0 min, respectively. The ee was 26% with R25 being the major enantiomer. In addition to ligand (+)-3, all other ligands,
including (-)-1, (-)-2, (-)-4, (+)-5, (-)-6, (+)-7, (-)-8, (+)-9, and (-)-10 were also
tested for the reaction. The yields ranged from 63% to 99%. The ees ranged from
0% to 26%.
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Chapter 4
Applications of Chiral Ferrosalen Ligands in catalysis

This chapter describes the applications of ferrosalen compounds (-)-1 to (-)10 (Figure 4.1) in the following catalytic reactions: enantioselective carbonyl-ene
reaction,

enantioselective

Strecker-type

reaction

and

enantioselective

silylcyanation.

Figure 4.1: Ferrosalen and Ferrosalen-type ligands used in asymmetric catalysis
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4.1 Enantioselective Carbonyl-ene reaction
4.1.1 Introduction
An ene reaction can be broadly classified as an alkene (ene) component to
react with a broad range of enophiles: alkenes, alkynes, allenes, carbonyls, imines,
etc. In this case, a carbonyl-ene reaction refers to the reaction of an alkene with a
carbonyl group. This type of reaction can be potentially used to build up a wide
range of products. From the mechanism, it comes with an appealing advantage of
atom efficiency: all of the atoms in the substrates end up in the product.89 The
general mechanism is shown in Scheme 4.1.

Scheme 4.1: General mechanism of an ene reaction
Theoretically, carbonyl-ene reaction can proceed without any catalysts.
However, due to the high energy barrier, it often needs very high temperature to
proceed. When a Lewis acid catalyst was used to activate the carbonyl group, the
reaction could proceed at room temperature or even lower temperature.
Enantioselective versions of this reaction started to draw attention of chemists
since 1980s. The chiral element was transferred from the chiral catalyst to the
substrate through the Lewis acid activation step (Scheme 4.2).
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Scheme 4.2: Chirality transfer of enantioselective carbonyl-ene reaction
During the development of catalysts for enantioselective carbonyl-ene
reaction, many effective ones have been discovered. For example, Ti-BINOL
complexes by Nakai/Mikami,90-91 C-2 symmetric Cu-Box catalyst by Evans,92-93
tridentate Cr(III)-Schiff base complexes by Jacobsen,94 and also the use of C-2
symmetric metal-salen complexes (figure 4.2).88

Figure 4.2: Example catalysts for enantioselective carbonyl-ene reaction

4.1.2 Result and discussion
For the initial studies, we examined the reaction with racemic ferrosalen
ligand (±)-11 and a known salen ligand 12 (Table 4.1). The catalysts were
synthesized by the known procedure of stirring the specific salen ligand with
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Co(OAc)2•4H2O in MeOH followed by hexafluoroantimonate adduct formation.
The benchmark catalytic reactions were carried out in toluene at room temperature
in the presence of 5 mol % of catalysts and excess of ethyl glyoxylate. In entry 1,
Product (±)-15 was formed at 100% conversion and 1% ee. This experiment
established the standard protocol for our studies; In entry 2, the enantioselectivity
was compared to the literature (46% ee).88 This result confirmed that the HPLC
analysis is effective and well-functioning. These two reactions were used as
benchmark reactions to the enantioselective catalysis.
Table 4.1
Benchmark carbonyl-ene reactions using (±)-11 and 12

entry

catalyst

Time (h)

Yield a (%)

eeb (%)

1

(±)-11

overnight

100

1

2

12

overnight

100

65c

a

Conversion determined by GC-MS. Experimental details can be found on page 74. b
Determined by chiral HPLC analysis using a Daicel Chiralcel AS-H column (program details
see experimental section). c (-)-enantiomer predominates as determined by comparation with
literature data.
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After establishing the standard conditions, enantiopure ferrosalen ligands
were tested (Figure 4.1 and Table 4.2). In entry 1, the reaction was carried out in
an ice bath and slowly warmed up to room temperature. Poor yield was obtained
and enantioselectivity was also low. Heating up the reaction did not help with the
enantioselectivity either (entry 2). The best selectivity was obtained in entry 8
using (-)-8 as ligand, which gave 29% ee with (-) isomer as the major product.
Ligand (+)-7, which is a diastereoisomer of (-)-8, was also tested for the reaction.
The configuration of the major enantiomer is (+). We also used ligands with the
bulkier Cp* [(+)-9] and CpPh5 [(-)-10] for the reaction. Unfortunately no ee was
found (entry 9 and 10). The reason could be the steric bulkiness on the ligands.
The active site for the substrate activation may be blocked. Besides Co, Ruferrosalen complexes were also tested as shown in entry 11 and 12, only 10% ee
was found when (+)-3-Ru (III) was used.
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Table 4.2
Ferrosalen complex catalyzed enantioselective carbonyl-ene reaction

a

entry

liganda

T (˚C)

solvent

yield (%)

eeb (%)

1

(-)-1

0 - rt

PhMe

20c

5

2

(-)-2

70

PhMe

43

3

3

(+)-3

rt

PhMe

42c

0

4

(-)-4

rt

PhMe

60c

0

5

(+)-5

rt

PhMe

81

0

6

(‐)‐6

rt

PhMe

88

0

7

(+)-7

rt

PhMe

99

10 (+)

8

(-)-8

rt

PhMe

78

29 (-)

9

(+)-9

rt

PhMe

72

0

10

(-)-10

rt

PhMe

56

0

11

(+)-3-Ru (III)

rt

12

(-)-8-Ru (III)d

rt

CH2Cl2
PhMe/
CH2Cl2

65

c

76

10(-)
0

Experimental details can be found on page 74. b Determined by chiral HPLC analysis using a
Daicel Chiralcel AS-H column (program details see experimental section on page 74), Specific
configurations determined by comparison with literature data. c Yield determined by GC-MS. d
10% catalyst loading.
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4.2 Enantioselective Strecker-type reaction
4.2.1 Introduction
The Strecker reaction is one of the most important and convenient methods
for the synthesis of α-amino acids. In the reaction, α-aminonitriles are prepared by
addition of hydrogen cyanide to an imine (Scheme 4.3), which can be hydrolyzed
to give the desired amino acid. The substrates are very cheap because the imines
can be readily prepared by the condensation of the corresponding aldehyde or
ketone with amines.

Scheme 4.3: General mechanism of enantioselective Strecker reaction
Stereoselective Strecker synthesis has been well developed due to the
importance of optically active α-amino acids in pharmaceutical industry.95 The
most developed method is asymmetric induction by using imines which already
bear chiral auxiliary groups.96-98 In late 1990s, the first catalytic enantioselective
version of the reaction was reported. Since then many successful chiral metal
catalysts have been discovered, which include aluminum, titanium, zirconium and
lanthanoid complexes (Figure 4.3).
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Figure 4.3: Known catalysts for enantioselective Strecker reaction

4.2.2 Result and discussion
We first optimized the reaction conditions using the racemic ligand (±)-19.
Aluminum was chosen to be the metal atom of the Lewis acid catalyst. As
compared to other salen-metal complexes, salen-AlCl is the most effective catalyst
in both conversion and enantioselectivity according to literature.44 The catalyst
was generated in situ by stirring (±)-1 (10 mol %) and diethyl aluminum chloride
(9 mol %) in anhydrous CH2Cl2 before adding the substrates. The reaction was
carried out at room temperature overnight then quenched with benzoyl chloride in
pyridine to stabilize the amino group. It was found that the conversion was 100%
based on the GC-MS analysis. HPLC analysis of the purified 18 shows the ratio of
the two enantiomers is 1:1. This experiment provided a standard for the
enantioselective version of the catalysis (Scheme 4.4).
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Scheme 4.4: Benchmark catalytic Strecker reaction using (±)-1
A series of ferrosalen ligands with different steric hindrance were tested for
the enantioselectivities as shown in Table 4.3. Because 100% conversion was
obtained in the benchmark reaction, it is possible that background reaction is
taking place in which no catalyst participated in the transformation. According to
the literature, the background reaction occur rapidly at room temperature, while it
is extremely slow at -70 °C.44 To test the effect of temperature on the selectivity of
the reaction, (-)-1 was used for the reaction at different temperatures (entries 1, 2,
and 3 in Table 4.3). At room temperature, 4% ee was obtained (entry 1). When the
reaction was started at 0 °C and then slowly warm up to room temperature, 8% ee
was obtained (entry 2). When the reaction was carried out at -78 °C and allowed to
warm up naturally during overnight, ee was increased to 20% (entry 3). The result
agreed with the literature44 that low temperature (-78 °C) should be used to
maximize ee. Under low temperature conditions, (-)-2 was found to have similar
selectivity to (-)-1 (entry 4, 18% ee). In entries 11 and 12, pentamethyl and
pentaphenyl substituted ligands (+)-9 and (-)-10 were tested. Interestingly, poor
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enantioselectivities was obtained. To avoid errors, which may cause low ees, these
reactions were repeated. Low ees were obtained again. The reason for the low
selectivities in entries 11 and 12 might be because the substituted ligands were too
bulky for the catalyst to coordinate with the imine, which prevented the catalyzed
reaction, and the product formed was from the competing background reaction.
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Table 4.3
Ferrosalen complex catalyzed enantioselective Strecker reaction

entry

catalysta

T (°C)

time

yieldb (%)

eec (%)

1

(-)-1

rt

overnight

100

4 (+)

2

(-)-1

0 – rt

overnight

100

8 (+)

3

(-)-1

-78 – rt

overnight

100

20 (+)

4

(-)-2

-78 – rt

overnight

100

18 (+)

5

(+)-3

-78 – rt

overnight

100

10 (+)

6

(-)-4

-78 – rt

overnight

100

4 (+)

7

(+)-5

-78 – rt

overnight

100

0

8

(-)-6

-78 – rt

overnight

100

6 (+)

9

(+)-7

-78 – rt

overnight

100

8 (-)

10

(-)-8

-78 – rt

overnight

100

12 (+)

11

(+)-9

-78 – rt

overnight

100

0

12

(-)-10

-78 – rt

overnight

100

3 (+)

a

ligand: 10 mol %, Et2AlCl: 9 mol %. Experimental details can be found on page 76.
Determined by GC-MS. c Determined by chiral HPLC analysis using a Daicel Chiralcel ASH column (program details see experimental section on page 76), specific configuration was
not identified.
b
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4.3 Enantioselective silylcyanation reaction
We also tested enantioselective silylcyanation reaction, a similar reaction to
Strecker-type reaction. The reactions were carried out by reacting benzaldehyde
with an excess of trimethylsilylcyanide (2.5 equiv.) using the optimized
conditions.99-100 The results are shown in Table 4.4. Compared to the Strecker-type
reaction, the enantioselectivities in the silylcyanation reaction were better
controlled by the chiral ligands, possibly because there was no or if there was,
slower background reaction. The best enantioselectivity obtained was 26% ee,
with (+)-3 as ligand. Interestingly, using (-)-4, the diastereoisomer of (+)-3,
product was obtained with the same (-) configuration (entry 4). The same (-)
configurations were also observed on (+)-5 and (-)-6 (entry 5 and 6). The reason
might be that the enantioselectivities for these reactions were predominantly
controlled by the chiral diphenylethylenediamine backbone. Pentamethyl and
pentaphenyl substituted ligands (+)-9 and (-)-10 were used in entry 9 and 10.
However, very low enantioselectivities were obtained.
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Table 4.4
Ferrosalen complex catalyzed enantioselective silylcyanation reaction

entry

ligand

T (˚C)

time (h)

yielda (%)

eeb (%)

1

(-)-1

-20

48

86

8 (+)

2

(-)-2

-20

48

99

12 (+)

3

(+)-3

-20

48

89

26 (-)

4

(-)-4

-20

48

87

12 (-)

5

(+)-5

-20

48

84

18 (-)

6

(-)-6

-20

48

77

16 (-)

7

(+)-7

-20

48

85

12 (+)

8

(-)-8

-20

48

88

20 (-)

9

(+)-9c

-20

24

96

8 (-)

d

-20

48

63

0

10
a

(-)-10

b

Isolated yield. Experimental details can be found on page 77. Determined by chiral HPLC
analysis using a Daicel Chiralcel AS-H column (program details see experimental section on
page 77), specific configuration determined by comparing the optical rotation data with the
c
literature 1 mol % ligand, 1 mol % Et2AlCl, 5 mol % Oct3PO. d 2.5 mol % ligand, 2.5 mol %
Et2AlCl, 7.5 mol % Oct3PO.
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4.4 Future directions
For the reactions tested above, enantioselectivities were low. This low
selectivity may be attributable to the reaction and the ligands. For the Strecker
reaction, one possible reason for low enantioselectivity could be the background
reaction, which competes with the catalyzed reaction. From the perspective of the
ligand structure, one reason for the low selectivities could be the lack of steric
hindrance at several open sites on our ligand framework. To solve this problem,
we proposed two solutions to modify the ligand structure.
The first solution for ligand modification is to change the backbone. By
constructing the salen framework with a diamine backbone that bears more bulky
groups might improve enantioselectivities. Scheme 4.5 lists the finished synthesis
of two noncommercial available amines. Compound 21 was obtained with 36%
overall yield in two steps. Compound 22 was synthesized by Grignard addition to
cyanogen which was prepared by a known procedure. Although a low yield was
obtained (23%), 22 was prepared on a gram scale.

92

Scheme 4.5: Synthesis of steric hindered diamines 21 and 22
Another solution is to increase steric hindrance on 5, 5′ positions (Figure
4.4). This is a possible solution because most successful salen ligands have bulky
groups such as tert-butyl or triisobutylsilyl groups on 3, 3′ and 5, 5′ positions
(Figure 4.4a). Figure 4.4b shows the catalytic mechanism of ferrosalen-metal
system. In this catalytic system, the substrate activation will occur in the way that
the planar chiral ferrocenyl groups will block the nucleophilic approach from the
site of 3′ to 5′ positions. The approach from the site of 3 to 5 positions will be
favored because of less steric hindrance. However, it is possible that the open sites
at the 5, 5′ positions could allow the approach of nucleophiles. In this case a good
way to improve the ligand structure would be to insert bulky groups at the 5, 5′
positions.
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Figure 4.4: Comparison of Jacobsen’s salen and ferrosalen framework
To increase the steric hindrance at the 5, 5′ positions, a functional group
needs to be inserted in the structural motif (+)-23 (Scheme 4.5). A synthetic route
was designed, which could use our synthetic strategy described in Chapter 2.
Starting with ester protected ferrocene derivative 27, 26 could be readily prepared
by reductive amination. We have tested this reaction, and the results are promising.
The methyl ester is then hydrolyzed and the acid is cyclized. Racemic 25 could be
obtained. Resolution of 25 will be achieved using the same chiral resolution
method we used in Chapter 2. After formylation of (+)-24 and aromatization,
substituted ferrosalen motif (+)-23 could be synthesized, which contains the bulky
tert-amino group.
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Scheme 4.5: Retro-synthetic design for the optimized ferrosalen structural motif

4.5 Experimental section
HPLC conditions for enantioselective catalytic reactions:
HPLC analysis of compounds 15, 18 and 19 were performed on a JASCO
LC-2000Plus System: pump, PU-2089Plus Quaternary Gradient; detector UV2075Plus; chiral analytical column, Chiracel AS-H (5 μm diameter, 100 Å, 250 ×
4.6 mm). All profiles were generated by detection of UV absorbance at 260 nm
using the linear gradient solvent system: 1% to 10% 2-propanol in hexanes over
30 min at a flow rate of 1 mL/min.
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Synthesis of steric hindered diamines 21 and 22:
20: To a round bottom flask containing malononitrile (0.116g, 1.756 mmol),
3,5-di-t-butylbenzyl bromide (1.089g, 3.846 mmol) and 30 mL THF was added tBuOK (0.432g, 3.846 mmol) under positive N2 pressure. This mixture was heated
at 50 °C overnight. The mixture was filtered through a celite pad using CH2Cl2,
the filtrate was evaporated, and the residue was purified by flash column
chromatography (SiO2, hexanes/Et2O 50:1) to give 20 as colorless oil (0.740g, 90%
yield). 1H NMR (CDCl3) δ 7.58 (s, 2H), 7.39 (s, 4H), 3.37 (s, 4H), 1.49 (s, 36H);
13

C NMR (CDCl3) δ 151.2, 131.3, 124.6, 122.3, 115.1, 44.1, 41.8, 34.8, 31.6.
21: A N2 filled round-bottom flask containing 20 (1.072g, 2.280 mmol) and

20 mL Et2O was cooled with an ice bath. Lithium aluminumhydride (0.260g,
6.830 mmol) was added in 3 portions under positive N2 flow. The reaction mixture
was allowed to warm up to rt naturally and stirred overnight. The reaction mixture
was cooled with an ice bath, 0.27 mL H2O, 0.26 mL 15% NaOH, 0.78 mL H2O
were added sequentially in 15 min. The mixture was stirred for additional 15 min
and was filtered through a celite pad using Et2O. The filtrate was collected and the
solvent was removed under reduced pressure. Purification by flash column
chromatography (SiO2, hexanes/Et2O/Et3N 50:50:5) gave 21 as a light yellow oil
(0.450g, 41% yield). 1H NMR (C6D6) δ 7.36 (s, 2H), 7.25 (s, 4H), 2.78 (s, 4H),

96

2.50 (s, 4H), 1.28 (s, 36H), 0.76 (br s, 4H); 13C NMR (C6D6) δ 150.2, 138.5, 125.3,
119.6, 45.6, 44.1, 41.1, 34.7, 31.6, 31.5.
22: Cyanogen was freshly prepared according to the literature procedure
and stored under -78 °C. 101 A two-neck round bottom flask containing cyanogen
(1.107g, 6.431 mmol) and 15 mL Et2O was cooled down to -78 °C,
benzylmagnesium chloride (25.6 mL, 51.2 mmol) was added dropwise. The
mixture was warmed up to rt in 45 min and was allowed to stir for additional 30
min. Titanium isopropoxide (5.6 mL, 19.11 mmol) was added dropwise and the
mixture was stirred at rt overnight. The mixture was cooled in an ice bath, and 100
mL aqueous NaOH (10%) was added dropwise. The mixture was vacuum filtered
and the filtrate was partitioned between EtOAc and aqueous NaOH (10%). The
organic phase was washed with brine (80 mL), dried over anhydrous Na2SO4, and
filtered. The solvent was removed under reduced pressure. Purification by flash
column chromatography (SiO2, hexanes/EtOAc 5:1) gave 22 as a light yellow oil
(0.622g, 23% yield). 1H NMR (CDCl3) δ 7.42-7.22 (m, 20H), 4.68 (s, 8H), 1.78
(br s, 4H); 13C NMR (CDCl3) δ 140.8, 128.5, 127.6, 127.0, 65.3.
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Conclusions
The requirement of enantiopure compounds for clinical applications has led
to significant progress in developing transition-metal catalyzed reactions in the
past decades. Due to the fact that most catalysts consist of a metal and one or more
chiral ligands, the development of chiral ligands that can offer high yields and
enantioselectivity are in a high demand. Although numerous discoveries have been
made in this area, most of the successful ligands are the result of hundreds of
failures and extensive optimizations.
In this dissertation, we have successfully designed and synthesized a new
chiral

ferrosalen

ligand

framework.

These

ligands

were

synthesized

stereoselectively using a highly effective chiral auxiliary approach. The method is
inexpensive and atom-economic. More sterically hindered ligand derivatives were
also synthesized with pentamethyl and pentaphenyl substituted ferrocene as the
starting materials. The structure of the ligand was confirmed by X-ray
crystallography study of one of the ligand-Cu(II) complex. The ligands have
unique structural features, thus they may find wide applications in asymmetric
catalysis.
We also explored the catalytic activities of these ferrosalen ligands in 3
asymmetric

catalytic

reactions:

enantioselective

carbonyl-ene

reaction,

enantioselective Strecker-type reaction and enantioselective silylcyanation. The
98

catalytic reactions were carried out with good chemical yield (up to 99%), and
enantioselectivities of up to 29% for the carbonyl-ene reaction, 20% for the
Strecker reaction and 26% for the silylcyanation reaction were observed. Although
the enantioselectivities are far from achieving the goal as successful chiral ligands,
it is encouraging that the ligands are configurationally stable and the structures can
be easily optimized for better tuning the catalytic activities.
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A.1 General Experimental

All reactions were performed in oven-dried glassware under a nitrogen
atmosphere using standard Schlenk techniques. Reagents and solvents available from
commercial sources were used as received unless otherwise noted. THF was distilled
from Na/benzophenone ketyl. MeOH was distilled over CaH2. Thin layer
chromatography (TLC) was performed using plates with silica gel 60F-254 over glass
support, 0.25 μm thickness. Flash column chromatography was performed using silica gel
with particle size of 32-63 μm. 1H and 13C NMR spectra were measured at 400 MHz and
100 MHz, respectively; chemical shifts (δ) were reported in reference to solvent peaks
(residue CHCl3 at δ 7.24 ppm for 1H and CDCl3 at δ 77.00 ppm for 13C).
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Figure A.1: 1H NMR spectrum of 7
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Figure A.2: 13C NMR spectrum of 7
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Figure A.3: 1H NMR spectrum of 10
120

Figure A.4: 13C NMR spectrum of 10
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Figure A.7: 1H NMR spectrum of 11b
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Figure A.8: 13C NMR spectrum of 11b
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Figure A.9: 1H NMR sspectrum off 11c
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Figure A.11: 1H NMR spectrum of 9
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B.1 1H and 13C NMR spectra of new compounds

Figure B.1: 1H NMR spectrum of (-)-1
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Figure B.2: 13C NMR spectrum of (-)-1
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Figure B.3: 1H NMR spectrum of (-)-2
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Figure B.4: 13C NMR spectrum of (-)-2
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Figure B.5: 1H NMR spectrum of (+)-3

141

FeCp

N

N

(+)-3

OH HO

Ph

Ph

FeCp

H NMR spectrum of (+)-3 in CDCl3

1

Figure B.6: 13C NMR spectrum of (+)-3
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Figure B.7: 1H NMR spectrum of (-)-4
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Figure B.8: 13C NMR spectrum of (-)-4
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Figure B.9: 1H NMR spectrum of (+)-5
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Figure B.10: 13C NMR spectrum of (+)-5
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Figure B.11: 1H NMR spectrum of (-)-6
147

Figure B.12: 13C NMR spectrum of (-)-6
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Figure B.13: 1H NMR spectrum of (+)-7
149

Figure B.14: 13C NMR spectrum of (+)-7
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Figure B.15: 1H NMR spectrum of (-)-8
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Figure B.16: 13C NMR spectrum of (-)-8
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Figure B.17: 1H NMR spectrum of 17a
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Figure B.18: 13C NMR spectrum of 17a
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Figure B.19: 1H NMR spectrum of 18a
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Figure B.20: 13C NMR spectrum of 18a
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Figure B.21: 1H NMR spectrum of (±)-19a
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Figure B.22: 13C NMR spectrum of (±)-19a
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Figure B.23: 1H NMR spectrum of (+)-19a
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Figure B.24: 13C NMR spectrum of (+)-19a
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Figure B.25: 1H NMR spectrum of (+)-22a
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Figure B.26: 13C NMR spectrum of (+)-22a
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Figure B.27: 1H NMR spectrum of (+)-9
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Figure B.28: 13C NMR spectrum of (+)-9
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Figure B.29: 1H NMR spectrum of 17b

165

17b

FeCp5Ph

O

CO2H

H NMR spectrum of 17b in CDCl3

1

Figure B.30: 13C NMR spectrum of 17b
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Figure B.31: 1H NMR spectrum of 18b
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Figure B.32: 13C NMR spectrum of 18b
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Figure B.33: 1H NMR spectrum of (±)-19b
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Figure B.34: 13C NMR spectrum of (±)-19b
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Figure B.35: 1H NMR spectrum of (-)-19b
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Figure B.36: 13C NMR spectrum of (-)-19b
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Figure B.37: 1H NMR spectrum of (-)-22b
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Figure B.38: 13C NMR spectrum of (-)-22b
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Figure B.39: 1H NMR spectrum of (-)-10
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Figure B.40: 13C NMR spectrum of (-)-10
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B.2 High resolution MS spectra of new compounds

Figure B.41: High resolution MS for (-)-2
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Figure B.44: High resolution MS for (+)-5
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Figure B.45: High resolution MS for (-)-6

Figure B.46: High resolution MS for (+)-7
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Figure B.47: High resolution MS for (-)-8
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Figure B.48: High resolution MS for (+)-9
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Figure B.49: High resolution MS for (-)-10

Figure B.50: High resolution MS for (-)-12
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Figure B.53: High resolution MS for (±)-19a
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Figure B.54: High resolution MS for (+)-19a
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Figure B.56: High resolution MS for 17b
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Figure B.57: High resolution MS for 18b
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Figure B.58: High resolution MS for (±)-19b
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Figure B.59: High resolution MS for (-)-19b
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Figure B.60: High resolution MS for (-)-22b
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C.1 Chiral HPLC profiles
Carbonyl-ene Reaction: Chiral HPLC profiles of 15:

Ratio of enantiomers: 49:51
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Figure C.1: HPLC profile for 15 using (±)-11-Co(III) as the catalyst
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Figure C.2: HPLC profile for 15 using 12-Co(III) as the catalyst
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Ratio of enantiomers: 55:45
30
20
10

21.313

16.780

Absorbance (260 nm)

40

0
0

5

10

15

20

25

30

[min.]

Time

Figure C.3: HPLC profile for 15 using (+)-7-Co(III) as the catalyst

Ratio of enantiomers: 36:64
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Figure C.4: HPLC profile for 15 using (-)-8-Co(III) as the catalyst
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Strecker-type Reaction: Chiral HPLC profiles of 18
Ratio of enantiomers: 46:50
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Figure C.5: HPLC profile for 18 using (-)-1-AlCl as the catalyst (rt)

Ratio of enantiomers: 42:51
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Figure C.6: HPLC profile for 18 using (-)-1-AlCl as the catalyst (0 °C - rt)
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Ratio of enantiomers: 39:61
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Figure C.7: HPLC profile for 18 using (-)-1-AlCl as the catalyst (-78 °C - rt)
Ratio of enantiomers: 41:59
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Figure C.8: HPLC profile for 18 using (-)-2-AlCl as the catalyst
Ratio of enantiomers: 45:55
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Figure C.9: HPLC profile for 18 using (+)-3-AlCl as the catalyst
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Ratio of enantiomers: 48:52
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Figure C.10: HPLC profile for 18 using (-)-4-AlCl as the catalyst
Ratio of enantiomers: 50:50
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Figure C.11: HPLC profile for 18 using (+)-5-AlCl as the catalyst
Ratio of enantiomers: 47:53
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Figure C.12: HPLC profile for 18 using (-)-6-AlCl as the catalyst
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Ratio of enantiomers: 54:46
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Figure C.13: HPLC profile for 18 using (+)-7-AlCl as the catalyst
Ratio of enantiomers: 44:56
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Figure C.14: HPLC profile for 18 using (-)-8-AlCl as the catalyst
Ratio of enantiomers: 43:46
25
20

11.733

5
0
0

5

10

21.205

17.920

10

18.773

15

5.931

Absorbance (260 nm)

30

15

20

25

30

[min.]

Time

Figure C.15: HPLC profile for 18 using (-)-10-AlCl as the catalyst
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Silylcyanation Reaction: Chiral HPLC profiles of 19
Ratio of enantiomers: 46:54
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Figure C.16: HPLC profile for 19 using (-)-1-AlCl as the catalyst
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Figure C.17: HPLC profile for 19 using (-)-2-AlCl as the catalyst
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Ratio of enantiomers: 63:37
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Figure C.18: HPLC profile for 19 using (+)-3-AlCl as the catalyst
Ratio of enantiomers: 56:44
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Figure C.19: HPLC profile for 19 using (-)-4-AlCl as the catalyst
Ratio of enantiomers: 59:41
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Figure C.20: HPLC profile for 19 using (+)-5-AlCl as the catalyst
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Ratio of enantiomers: 58:42
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Figure C.21: HPLC profile for 19 using (-)-6-AlCl as the catalyst
Ratio of enantiomers: 44:56
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Figure C.22: HPLC profile for 19 using (+)-7-AlCl as the catalyst
Ratio of enantiomers: 60:40
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Figure C.23: HPLC profile for 19 using (-)-8-AlCl as the catalyst
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Ratio of enantiomers: 54:46
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Figure C.24: HPLC profile for 19 using (+)-9-AlCl as the catalyst:

Ratio of enantiomers: 51:49
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Figure C.25: HPLC profile for 19 using (-)-10-AlCl as the catalyst:

198

C.2 1H and 13C NMR spectra of new compounds

Figure C.26: 1H NMR spectrum of 20
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Figure C.27: 13C NMR spectrum of 20
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Figure C.28: 1H NMR spectrum of 21
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Figure C.29: 13C NMR spectrum of 21
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Figure C.30: 1H NMR spectrum of 22
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Figure C.31: 13C NMR spectrum of 22
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